{
  "meta": {
    "title": "17_Reversible_Methods_Of_Contraception",
    "url": "https://brainandscalpel.vercel.app/17-reversible-methods-of-contraception-5f46f011.html",
    "scrapedAt": "2025-11-30T06:56:52.373Z"
  },
  "questions": [
    {
      "id": 53350,
      "choices": [
        {
          "id": 238519,
          "text": "RBT method"
        },
        {
          "id": 238520,
          "text": "Rhythm method"
        },
        {
          "id": 238521,
          "text": "Lactational anerorrhea"
        },
        {
          "id": 238522,
          "text": "Withdrawl method"
        }
      ],
      "text": "Which natural family planning method is based on ogino knauss theory :",
      "unique_key": "Q5643043",
      "question_audio": null,
      "question_video": null,
      "map_id": 34541041,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Rhythm Method. The Rhythm Method is based on the Ogino-Knauss theory, which involves estimating the fertile window in a woman's menstrual cycle. According to this theory, ovulation occurs roughly 14 days before the start of the next menstrual period. The Rhythm Method works by tracking the length of menstrual cycles over several months and using this information to predict the days when a woman is most fertile. This method aims to avoid intercourse during the fertile period to prevent pregnancy. It is a natural family planning method that relies on regular cycles and knowledge of one's body, though it is less reliable if cycles are irregular. Now, let’s look at the incorrect options: A. RBT Method RBT (Return of Basal Temperature) method is similar in nature but is based on tracking a woman's basal body temperature (BBT) to predict ovulation. The temperature rises after ovulation, and the method identifies this change. It is different from the Rhythm Method because it doesn't rely on the length of menstrual cycles but on daily temperature readings. Therefore, it is not based on the Ogino-Knauss theory. C. Lactational Amenorrhea Lactational Amenorrhea Method (LAM) is a natural contraceptive method based on the biological process of breastfeeding. When a woman is breastfeeding exclusively (without supplementation) and her period has not yet returned, she may not ovulate, thus reducing the chances of pregnancy. It does not rely on the Ogino-Knauss theory, as it is based on the hormonal effects of breastfeeding rather than the tracking of menstrual cycles. D. Withdrawal Method The Withdrawal Method involves the male partner withdrawing his penis from the vagina before ejaculation. This method has no scientific connection to the Ogino-Knauss theory, as it is based on the actions of the male partner rather than tracking ovulation or menstrual cycles. It is one of the less reliable methods of contraception.",
      "correct_choice_id": 238520,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/23548831705641509/23548831705641509.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/23548831705641509/23548831705641509.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53351,
      "choices": [
        {
          "id": 238523,
          "text": "Abstinence is needed for only a few days in a month"
        },
        {
          "id": 238524,
          "text": "It is associated with no costs"
        },
        {
          "id": 238525,
          "text": "Safe period can also be observed using temperature rhythm or mucous method"
        },
        {
          "id": 238526,
          "text": "Ectopic pregnancy is a reported complication of calendar method"
        }
      ],
      "text": "Which of the following statements about calendar method (Rhythm method) is false:",
      "unique_key": "Q1120546",
      "question_audio": null,
      "question_video": null,
      "map_id": 34617836,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Ectopic pregnancy is a reported complication of calendar method. Ectopic pregnancy is not a typical complication of the calendar (Rhythm) method. The calendar method works by estimating the \"safe\" days when a woman is least likely to conceive, based on the length and pattern of her menstrual cycle. It is a method of contraception based on timing, and while it has lower reliability compared to other methods, it does not specifically increase the risk of ectopic pregnancy, which typically occurs due to issues such as blocked fallopian tubes or previous infections. The risks associated with the calendar method mainly involve unplanned pregnancies due to incorrect tracking or irregular cycles, not ectopic pregnancies. Now, let’s look at the incorrect options: A. Abstinence is needed for only a few days in a month This statement is true. The Rhythm method requires abstaining from intercourse during the woman's fertile period, which typically lasts for a few days around ovulation. This period is estimated based on previous menstrual cycles. Abstinence is generally not required for the entire month, just for a limited number of days when the woman is likely to be fertile. B. It is associated with no costs This statement is also true. The calendar method is a natural form of family planning, and there are no direct financial costs involved since it relies on the woman's observation of her menstrual cycles. No devices, medications, or doctor visits are necessary to practice this method. C. Safe period can also be observed using temperature rhythm or mucous method This statement is true as well. The safe period can indeed be observed through other methods like the temperature rhythm method (basal body temperature tracking) or the cervical mucus method. These methods can provide additional information to help identify when a woman is fertile and when she is not, which is in line with the calendar method's goal of identifying a \"safe period.\"",
      "correct_choice_id": 238526,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53352,
      "choices": [
        {
          "id": 238527,
          "text": "Monitoring BBT"
        },
        {
          "id": 238528,
          "text": "Cervical mucus method"
        },
        {
          "id": 238529,
          "text": "Rhythm method"
        },
        {
          "id": 238530,
          "text": "Coitus interruptus method"
        }
      ],
      "text": "Billing’s method of contraception refers to;",
      "unique_key": "Q2048199",
      "question_audio": null,
      "question_video": null,
      "map_id": 34836639,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Cervical Mucus Method. The Billings method of contraception is based on the observation of cervical mucus changes throughout the menstrual cycle. The method involves tracking the consistency, amount, and texture of the cervical mucus to determine the most fertile period. According to the Billings method, a woman is most fertile when her cervical mucus is clear, slippery, and stretchy (like raw egg white). During the fertile window, abstinence or the use of contraception is recommended. This method is one of the natural family planning techniques and does not rely on any medications or devices. Now, let’s look at the incorrect options: A. Monitoring BBT Monitoring basal body temperature (BBT) is a different method of natural family planning, often used in conjunction with the cervical mucus method. The BBT method involves taking the temperature every morning before getting out of bed and observing slight increases in temperature after ovulation. While the BBT method can be used to track fertility, it is not the same as the Billings method, which specifically focuses on changes in cervical mucus. C. Rhythm Method The Rhythm method is based on calculating the fertile period by tracking menstrual cycle lengths over several months. It relies on the idea that ovulation occurs around day 14 of the menstrual cycle and that the fertile window is within a few days before and after ovulation. This is different from the Billings method, which uses cervical mucus as the primary indicator of fertility rather than cycle length. D. Coitus Interruptus Method Coitus interruptus, or the withdrawal method, involves the male partner withdrawing his penis from the vagina before ejaculation. It is a behavioral method of contraception but has no connection to the Billings method, which focuses on tracking fertility signs such as cervical mucus, not the timing of intercourse.",
      "correct_choice_id": 238528,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/39886771705641521/39886771705641521.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/39886771705641521/39886771705641521.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53353,
      "choices": [
        {
          "id": 238531,
          "text": "Acrosomal enzyme"
        },
        {
          "id": 238532,
          "text": "Cervical enzyme alteration"
        },
        {
          "id": 238533,
          "text": "Glucose uptake inhibition by sperms"
        },
        {
          "id": 238534,
          "text": "Disruption of cell membrane"
        }
      ],
      "text": "Spermicidal jelly acts through;",
      "unique_key": "Q1898010",
      "question_audio": null,
      "question_video": null,
      "map_id": 34637755,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Disruption of cell membrane. Spermicidal jelly primarily works by disrupting the sperm's cell membrane. The active ingredients in spermicides, such as nonoxynol-9, break down the lipid membranes of sperm cells, which leads to the sperm's immobilization and eventual death. This mechanism prevents sperm from reaching the egg and fertilizing it, thus acting as a barrier to conception. Now, let’s look at the incorrect options: A. Acrosomal enzyme Acrosomal enzymes are involved in the fertilization process, helping sperm penetrate the egg's outer layers. However, spermicidal jelly does not act through acrosomal enzymes. The spermicides work by directly damaging the sperm cells' membranes, not by interfering with their acrosomal function. B. Cervical enzyme alteration Spermicidal jelly does not act by altering cervical enzymes. While cervical mucus can be altered by hormonal methods of contraception, spermicides work by directly attacking the sperm cell membrane, not by altering the enzyme activity in the cervix. C. Glucose uptake inhibition by sperms Inhibition of glucose uptake is not the primary action of spermicidal jelly. While sperm rely on glucose for energy, spermicides primarily function by disrupting the sperm's cellular integrity, not by inhibiting glucose uptake.",
      "correct_choice_id": 238534,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/424841705641531/424841705641531.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/424841705641531/424841705641531.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53354,
      "choices": [
        {
          "id": 238535,
          "text": "20 mcg"
        },
        {
          "id": 238536,
          "text": "35 mcg"
        },
        {
          "id": 238537,
          "text": "50 mcg"
        },
        {
          "id": 238538,
          "text": "75 mcg"
        }
      ],
      "text": "Minimum effective dose of ethinyl estradiol in combination oral pills is:",
      "unique_key": "Q9315523",
      "question_audio": null,
      "question_video": null,
      "map_id": 34107454,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) 20 mcg. The minimum effective dose of ethinyl estradiol in combination oral contraceptive pills is 20 mcg. This low dose is generally effective in preventing pregnancy while minimizing side effects associated with higher doses of estrogen, such as nausea, headaches, and blood clots. Modern combination oral contraceptives typically contain between 20 mcg and 35 mcg of ethinyl estradiol, and studies have shown that 20 mcg is sufficient to provide effective contraception for most women. Now, let’s look at the incorrect options: B. 35 mcg While 35 mcg of ethinyl estradiol is a common dose in many combination oral contraceptives, it is not the minimum effective dose. Higher doses may be used in specific cases or in older formulations, but lower doses (like 20 mcg) are often preferred for their effectiveness and reduced risk of side effects. C. 50 mcg A dose of 50 mcg of ethinyl estradiol is relatively high for modern oral contraceptives and is rarely used today. It was more common in older formulations but is generally avoided due to the increased risk of side effects, such as venous thromboembolism. Lower doses like 20 mcg or 35 mcg are preferred for better safety profiles. D. 75 mcg 75 mcg is an even higher dose that is not typically used in combination oral contraceptives. Such a dose would be associated with a significantly higher risk of side effects, including cardiovascular complications. Therefore, it is not considered a standard or effective dose in modern contraceptive pills.",
      "correct_choice_id": 238535,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/39240751705641541/39240751705641541.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/39240751705641541/39240751705641541.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53355,
      "choices": [
        {
          "id": 238539,
          "text": "Are more lipid friendly"
        },
        {
          "id": 238540,
          "text": "Decreases the risk of venous thromboembolism"
        },
        {
          "id": 238541,
          "text": "Increase the risk of breakthrough bleeding"
        },
        {
          "id": 238542,
          "text": "Are not used for emergency contraception"
        }
      ],
      "text": "Third generation oral contraceptive pills containing norgestimate and gestodne along with estrogens:",
      "unique_key": "Q8640675",
      "question_audio": null,
      "question_video": null,
      "map_id": 34199325,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Are more lipid friendly. Third-generation oral contraceptives, which contain synthetic progestins like norgestimate and gestodene, are considered more \"lipid-friendly\" compared to earlier generations of progestins (e.g., levonorgestrel). These newer progestins have a lower impact on lipid metabolism, which means they are less likely to cause undesirable changes in blood lipid profiles, such as increased LDL (low-density lipoprotein) or decreased HDL (high-density lipoprotein). This makes them a better option for women who are concerned about the potential cardiovascular effects of contraception. Now, let’s look at the incorrect options: B. Decreases the risk of venous thromboembolism Third-generation oral contraceptives do not decrease the risk of venous thromboembolism (VTE); in fact, they are associated with a slightly higher risk compared to second-generation contraceptives. Progestins like norgestimate and gestodene are believed to have a higher prothrombotic effect, increasing the risk of blood clots, although the risk remains relatively low compared to women not using hormonal contraception. C. Increase the risk of breakthrough bleeding Third-generation oral contraceptives are generally associated with a lower incidence of breakthrough bleeding compared to older formulations. This is due to the more refined progestin formulations, which help stabilize the endometrial lining more effectively. Breakthrough bleeding can still occur, but it is not characteristic of third-generation pills. D. Are not used for emergency contraception Third-generation oral contraceptives can be used for emergency contraception, though they are not the first choice. Levonorgestrel-based pills are more commonly used for emergency contraception. However, any combined oral contraceptive (including third-generation ones) can be used in high doses for emergency contraception, though this is less effective and not the preferred method.",
      "correct_choice_id": 238539,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/27950581705641552/27950581705641552.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/27950581705641552/27950581705641552.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53356,
      "choices": [
        {
          "id": 238543,
          "text": "Preventing ovulation"
        },
        {
          "id": 238544,
          "text": "Inhibiting implantation"
        },
        {
          "id": 238545,
          "text": "Bringing about alterations in cervical mucus"
        },
        {
          "id": 238546,
          "text": "All of the above"
        }
      ],
      "text": "The progesterone component of OCP acts by :",
      "unique_key": "Q5594761",
      "question_audio": null,
      "question_video": null,
      "map_id": 34254255,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) All of the above. The progesterone component of oral contraceptive pills (OCPs) acts through multiple mechanisms to prevent pregnancy. First, it prevents ovulation by inhibiting the secretion of hormones that are necessary for the maturation and release of an egg. Second, it inhibits implantation by altering the endometrial lining, making it less receptive to a fertilized egg. Third, progesterone causes alterations in cervical mucus, thickening it, which makes it more difficult for sperm to enter the uterus and reach an egg. These combined effects make oral contraceptives highly effective in preventing pregnancy. Now, let’s look at the incorrect options: A. Preventing ovulation While this is true, it does not fully capture the entire action of the progesterone component in oral contraceptives. The progesterone in OCPs does prevent ovulation, but this is only one of the mechanisms by which they prevent pregnancy. Since the question asks for the action of the progesterone component specifically, this is part of the correct answer, but not the whole picture. B. Inhibiting implantation Progesterone does indeed alter the endometrial lining, making it less suitable for implantation. However, this is only one part of its action. The fact that it also prevents ovulation and changes cervical mucus means the progesterone component of OCPs works through a broader range of effects to prevent pregnancy, not just by inhibiting implantation. C. Bringing about alterations in cervical mucus This is correct, as progesterone thickens cervical mucus, making it harder for sperm to swim through and reach the egg. However, this alone doesn’t fully explain how OCPs work, as preventing ovulation and inhibiting implantation also play significant roles. Therefore, this is just one aspect of the overall contraceptive action of progesterone in OCPs.",
      "correct_choice_id": 238546,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/41632021705641562/41632021705641562.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/41632021705641562/41632021705641562.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53357,
      "choices": [
        {
          "id": 238547,
          "text": "30 mcg"
        },
        {
          "id": 238548,
          "text": "50 mcg"
        },
        {
          "id": 238549,
          "text": "10 mcg"
        },
        {
          "id": 238550,
          "text": "80 mcg"
        }
      ],
      "text": "Amount of estrogen in Mala D is :",
      "unique_key": "Q1999098",
      "question_audio": null,
      "question_video": null,
      "map_id": 34092659,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) 30 mcg. Mala D, a commonly used combined oral contraceptive pill, contains 30 mcg of ethinyl estradiol (the estrogen component). This is a standard amount of estrogen in many low-dose combined oral contraceptives, designed to provide effective contraception while minimizing the risk of estrogen-related side effects such as nausea, headaches, and blood clots. The 30 mcg dose is sufficient to suppress ovulation and provide effective contraception when taken correctly. Now, let’s look at the incorrect options: B. 50 mcg Mala D does not contain 50 mcg of estrogen. Although older formulations of oral contraceptives used higher doses of estrogen (such as 50 mcg), modern formulations like Mala D are designed with lower doses (30 mcg) to reduce the risks associated with higher estrogen levels, including cardiovascular issues. C. 10 mcg A dose of 10 mcg of estrogen is too low for a combined oral contraceptive pill like Mala D. While some very low-dose pills may contain estrogen amounts near this range, they are typically designed for specific uses, and Mala D is not one of them. The estrogen content in Mala D is 30 mcg. D. 80 mcg An estrogen dose of 80 mcg is much higher than what is found in Mala D. Such a high dose would significantly increase the risk of estrogen-related side effects and is not typical in modern oral contraceptives. The dose in Mala D is specifically designed to balance effectiveness with safety.",
      "correct_choice_id": 238547,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/70745731705641576/70745731705641576.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/70745731705641576/70745731705641576.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53358,
      "choices": [
        {
          "id": 238551,
          "text": "Salpingitis"
        },
        {
          "id": 238552,
          "text": "Hepatic adenoma"
        },
        {
          "id": 238553,
          "text": "Ovary CA"
        },
        {
          "id": 238554,
          "text": "Fibroadenosis"
        }
      ],
      "text": "Oral contraceptive pills decrease incidence of all of the following conditions except :",
      "unique_key": "Q5728861",
      "question_audio": null,
      "question_video": null,
      "map_id": 34817965,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Hepatic adenoma. Oral contraceptive pills (OCPs) are associated with an increased risk of hepatic adenomas, which are benign liver tumors. This risk is due to the influence of estrogen, which can promote the growth of these tumors in the liver. Although the incidence is rare, long-term use of OCPs, especially those with higher doses of estrogen, can contribute to the development of hepatic adenomas. Therefore, OCPs do not decrease the incidence of this condition; instead, they may increase it. Now, let’s look at the incorrect options: A. Salpingitis OCPs decrease the risk of salpingitis, which is inflammation of the fallopian tubes, often caused by pelvic inflammatory disease (PID). This is because OCPs thicken cervical mucus, making it more difficult for bacteria to ascend into the uterus and fallopian tubes, thereby reducing the risk of infections like salpingitis. C. Ovary CA (Ovarian Cancer) OCPs are known to reduce the risk of ovarian cancer. By suppressing ovulation, OCPs reduce the number of times the ovarian epithelium is disrupted during a woman’s lifetime, which is believed to lower the risk of malignant transformation. This protective effect is long-lasting, even after discontinuation of OCPs. D. Fibroadenosis OCPs help reduce the incidence of fibroadenosis (fibrocystic breast disease). The hormonal regulation provided by OCPs stabilizes fluctuating hormone levels, reducing the formation of cysts and alleviating symptoms associated with fibroadenosis, such as breast pain and lumpiness.",
      "correct_choice_id": 238552,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/2772081705641591/2772081705641591.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/2772081705641591/2772081705641591.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53359,
      "choices": [
        {
          "id": 238555,
          "text": "Ovarian carcinoma"
        },
        {
          "id": 238556,
          "text": "Endometrial carcinoma"
        },
        {
          "id": 238557,
          "text": "Uterine sarcoma"
        },
        {
          "id": 238558,
          "text": "Carcinoma cervix"
        }
      ],
      "text": "Use of OCP’s are known to protect against following malignancies except :",
      "unique_key": "Q8356881",
      "question_audio": null,
      "question_video": null,
      "map_id": 34197848,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Carcinoma cervix. Oral contraceptive pills (OCPs) are not protective against carcinoma of the cervix. In fact, long-term use of OCPs has been associated with a slightly increased risk of cervical cancer. This increased risk may be due to hormonal influences on the cervical epithelium, which might make it more susceptible to persistent infection with high-risk types of human papillomavirus (HPV), the primary cause of cervical cancer. However, the risk is mitigated by regular cervical screening and HPV vaccination. Now, let’s look at the incorrect options: A. Ovarian carcinoma OCPs provide significant protection against ovarian cancer. By suppressing ovulation, they reduce the number of times the ovarian epithelium is disrupted, which decreases the likelihood of malignant transformation. This protective effect is long-lasting and increases with the duration of OCP use. B. Endometrial carcinoma OCPs also reduce the risk of endometrial cancer. The progestin component in OCPs counteracts the proliferative effects of estrogen on the endometrial lining, lowering the risk of endometrial hyperplasia and subsequent malignancy. This protective effect persists even after discontinuing OCPs. C. Uterine sarcoma While data on uterine sarcomas are limited, OCPs are thought to have a neutral or slightly protective effect against these rare malignancies due to their role in hormonal regulation. However, the evidence is not as robust as it is for ovarian and endometrial cancers.",
      "correct_choice_id": 238558,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/64900301705641603/64900301705641603.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/64900301705641603/64900301705641603.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53360,
      "choices": [
        {
          "id": 238559,
          "text": "Ca endometrium"
        },
        {
          "id": 238560,
          "text": "Ca breast"
        },
        {
          "id": 238561,
          "text": "Rheumatoid arthritis"
        },
        {
          "id": 238562,
          "text": "Endometriosis"
        }
      ],
      "text": "Non contraceptive use of OCPs are all except :",
      "unique_key": "Q3028306",
      "question_audio": null,
      "question_video": null,
      "map_id": 34536210,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Ca breast. Oral contraceptive pills (OCPs) are not used for the non-contraceptive purpose of treating or preventing breast cancer. In fact, some studies have suggested a slight increase in the risk of breast cancer with prolonged use of OCPs, especially in younger women or those with a family history of breast cancer. Therefore, OCPs are not used for the treatment or prevention of breast cancer, making this the correct answer. Now, let’s look at the incorrect options: A. Ca endometrium OCPs are used for the non-contraceptive purpose of reducing the risk of endometrial cancer. The progestin component in OCPs helps protect the endometrium by counteracting the proliferative effects of estrogen. This effect significantly lowers the risk of endometrial hyperplasia and, consequently, endometrial cancer. C. Rheumatoid arthritis OCPs have been found to provide relief in the symptoms of rheumatoid arthritis (RA). The hormonal effects of OCPs, particularly the progestin component, can reduce the inflammation and joint pain associated with RA. This is one of the non-contraceptive uses of OCPs, especially in women with moderate RA symptoms. D. Endometriosis OCPs are commonly used to manage endometriosis. They help reduce the growth of endometrial tissue outside the uterus by suppressing ovulation and stabilizing hormone levels. This can reduce pain and bleeding associated with the condition, making OCPs a common treatment option for women with endometriosis.",
      "correct_choice_id": 238560,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/2822101705641616/2822101705641616.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/2822101705641616/2822101705641616.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53361,
      "choices": [
        {
          "id": 238563,
          "text": "Dysmenorrhea"
        },
        {
          "id": 238564,
          "text": "Mastalgia"
        },
        {
          "id": 238565,
          "text": "Nausea"
        },
        {
          "id": 238566,
          "text": "Chloasma"
        }
      ],
      "text": "OCP’s cause all except :",
      "unique_key": "Q5882112",
      "question_audio": null,
      "question_video": null,
      "map_id": 34426146,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Dysmenorrhea. Oral contraceptive pills (OCPs) are known to reduce dysmenorrhea (painful periods). By suppressing ovulation and stabilizing hormone levels, OCPs help alleviate the menstrual cramps that are typically associated with dysmenorrhea. This makes dysmenorrhea an unlikely effect of OCPs, as they are generally used to improve or eliminate menstrual pain. Now, let’s look at the incorrect options: B. Mastalgia Mastalgia (breast pain or tenderness) is a known side effect of OCPs. The hormonal fluctuations caused by the estrogen and progestin in OCPs can lead to changes in breast tissue, resulting in discomfort or tenderness in some women. This is a common side effect, especially during the first few months of using OCPs. C. Nausea Nausea is another common side effect of OCPs, particularly when starting the pill or when a higher dose of estrogen is used. This side effect typically occurs in the initial months of use and tends to subside over time as the body adjusts to the hormones. Nausea can also be alleviated by taking the pill with food or at night. D. Chloasma Chloasma, or melasma (skin discoloration, often referred to as the \"mask of pregnancy\"), is another known side effect of OCPs. The estrogen component of OCPs can stimulate increased pigmentation, especially in women who are exposed to sunlight. This typically manifests as dark patches on the face and may be more pronounced in women with darker skin tones.",
      "correct_choice_id": 238563,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/31551971705641628/31551971705641628.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/31551971705641628/31551971705641628.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53362,
      "choices": [
        {
          "id": 238567,
          "text": "Diabetes"
        },
        {
          "id": 238568,
          "text": "Hypertension"
        },
        {
          "id": 238569,
          "text": "Obesity"
        },
        {
          "id": 238570,
          "text": "Impaired liver function"
        }
      ],
      "text": "In a young female of reproductive age an absolute contraindication for prescribing OCP’s is :",
      "unique_key": "Q2447767",
      "question_audio": null,
      "question_video": null,
      "map_id": 34836026,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Impaired liver function. Impaired liver function is an absolute contraindication for prescribing oral contraceptive pills (OCPs) because the liver plays a crucial role in metabolizing hormones, including estrogen and progestin. In individuals with liver dysfunction, the metabolism of these hormones may be impaired, leading to potentially dangerous complications, such as an increased risk of blood clotting, liver damage, or exacerbation of liver disease. Therefore, OCPs should be avoided in patients with impaired liver function to reduce the risk of these serious side effects. Now, let’s look at the incorrect options: A. Diabetes While diabetes can increase the risk of complications with hormonal contraception, it is not an absolute contraindication in a young female with well-controlled blood sugar levels. OCPs can be prescribed to women with diabetes, but caution should be exercised, particularly in those with complications like diabetic retinopathy, nephropathy, or neuropathy, as OCPs may increase the risk of cardiovascular events in such individuals. Regular monitoring and management are essential in these cases. B. Hypertension Hypertension is not an absolute contraindication for prescribing OCPs, but it is a relative contraindication, particularly in women with poorly controlled high blood pressure. Estrogen in OCPs can raise blood pressure, and using them in women with hypertension increases the risk of cardiovascular complications, such as stroke or heart attack. If blood pressure is well-controlled (below 140/90 mm Hg), OCPs may be prescribed with close monitoring. C. Obesity Obesity is also a relative contraindication rather than an absolute one. While obesity increases the risk of complications from OCPs, such as thrombosis or metabolic issues, it is not an absolute contraindication. However, in women with a body mass index (BMI) greater than 35, the efficacy of some OCPs may be reduced, so healthcare providers may choose alternative contraception methods, such as intrauterine devices (IUDs) or implants.",
      "correct_choice_id": 238570,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/38317771705641822/38317771705641822.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/38317771705641822/38317771705641822.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53363,
      "choices": [
        {
          "id": 238571,
          "text": "Failure @ 0.3/100 WY"
        },
        {
          "id": 238572,
          "text": "150 mg/3 monthly delivered"
        },
        {
          "id": 238573,
          "text": "Weight gain"
        },
        {
          "id": 238574,
          "text": "Glucose intolerance occur"
        },
        {
          "id": 238575,
          "text": "Anemia improves"
        }
      ],
      "text": "Which is not true about DMPA",
      "unique_key": "Q4511920",
      "question_audio": null,
      "question_video": null,
      "map_id": 34411839,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Glucose intolerance occurs. Depo-Provera (DMPA), a depot medroxyprogesterone acetate injection, does not typically cause glucose intolerance in most users. While there may be some effects on glucose metabolism in a small subset of women, glucose intolerance is not a well-documented or primary side effect of DMPA. Therefore, this statement is not true about DMPA. Now, let’s look at the incorrect options: A. Failure @ 0.3/100 WY DMPA has a very low failure rate, estimated at 0.3 pregnancies per 100 women per year (0.3/100 WY). This makes it one of the most effective forms of contraception. It is highly effective because it is administered via injection every three months, ensuring consistent hormone levels in the body. B. 150 mg/3 monthly delivered DMPA is typically administered in a dose of 150 mg every three months (also referred to as every 12 weeks). This is the standard dosage for the intramuscular injection, which is the most commonly used form of DMPA. C. Weight gain Weight gain is a well-documented side effect of DMPA. Many women experience an increase in appetite and subsequent weight gain while using this contraceptive method. It is one of the more common side effects and may be significant for some users. E. Anemia improves DMPA can actually help improve anemia in some women, especially those with heavy menstrual bleeding or those who are at risk for iron-deficiency anemia. By suppressing menstruation, DMPA reduces menstrual blood loss, which can be beneficial for women who have anemia due to heavy periods.",
      "correct_choice_id": 238574,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/7167931705641838/7167931705641838.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/7167931705641838/7167931705641838.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53364,
      "choices": [
        {
          "id": 238576,
          "text": "Menorrhagia"
        },
        {
          "id": 238577,
          "text": "Metrorrhagia"
        },
        {
          "id": 238578,
          "text": "Polymenorrhea"
        },
        {
          "id": 238579,
          "text": "Amenorrhea"
        }
      ],
      "text": "In a woman on subdermal progesterone implant, the menstrual abnormality seen is :",
      "unique_key": "Q8170733",
      "question_audio": null,
      "question_video": null,
      "map_id": 34313218,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Metrorrhagia. A subdermal progesterone implant, such as the Nexplanon or Implanon, is a highly effective long-acting reversible contraceptive that is known to cause metrorrhagia (irregular bleeding or spotting between periods) in some women. While the hormonal effects of the implant often lead to irregular menstrual bleeding, metrorrhagia is one of the most commonly reported abnormalities. Over time, some women may experience lighter or absent periods, but irregular spotting between periods is a frequent issue, particularly during the first few months of use. Now, let’s look at the incorrect options: A. Menorrhagia Menorrhagia refers to heavy menstrual bleeding, which is not a typical side effect of the progesterone implant. In fact, many women using the implant experience lighter periods or even amenorrhea (absence of menstruation). While some women may experience heavier bleeding initially, menorrhagia is not a common or consistent side effect of this contraceptive method. C. Polymenorrhea Polymenorrhea, which refers to abnormally frequent periods (i.e., having a period more often than every 21 days), is also not typically associated with the progesterone implant. Most users of the implant report a reduction in the frequency and duration of menstrual bleeding, with many experiencing either lighter periods or no periods at all. Polymenorrhea is not a characteristic side effect of the implant. D. Amenorrhea Amenorrhea (the absence of menstruation) can occur in some women using the progesterone implant, particularly after prolonged use. This is a common and generally accepted side effect of the implant, as the hormonal effect of the implant often suppresses ovulation and endometrial growth, leading to no menstrual bleeding. However, metrorrhagia (irregular bleeding) is more commonly reported in the early stages of use, whereas amenorrhea might occur after longer-term use, making it less characteristic of the implant’s immediate effects.",
      "correct_choice_id": 238577,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/38408901705641851/38408901705641851.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/38408901705641851/38408901705641851.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53365,
      "choices": [
        {
          "id": 238580,
          "text": "Menorrhagia"
        },
        {
          "id": 238581,
          "text": "Dysmenorrhea"
        },
        {
          "id": 238582,
          "text": "Premenstrual symptoms"
        },
        {
          "id": 238583,
          "text": "Pelvic inflammatory disease"
        }
      ],
      "text": "Use of Levo-Norgestrel releasing, IUCD is helpful in all of the following conditions except :",
      "unique_key": "Q4587013",
      "question_audio": null,
      "question_video": null,
      "map_id": 34616430,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Premenstrual symptoms. Levo-Norgestrel-releasing intrauterine devices (IUDs), such as the Mirena IUD, are primarily used for contraception and can also be beneficial in treating conditions like menorrhagia, dysmenorrhea, and even reducing the risk of pelvic inflammatory disease (PID). However, they are not specifically used to treat premenstrual symptoms (PMS). While the hormonal effect of the IUD can impact menstrual cycles, it does not directly address the mood swings, irritability, or other emotional and physical symptoms associated with PMS. Thus, it is not considered a treatment for premenstrual symptoms. Now, let’s look at the incorrect options: A. Menorrhagia Levo-Norgestrel-releasing IUDs are particularly effective in treating menorrhagia (heavy menstrual bleeding). The progestin released by the IUD thins the endometrial lining, leading to lighter and less frequent periods. Many women experience a significant reduction in menstrual bleeding after the IUD is inserted, making it a widely used treatment option for menorrhagia. B. Dysmenorrhea The treatment of dysmenorrhea (painful periods) is another benefit of the Levo-Norgestrel-releasing IUD. The progestin hormone released by the device helps reduce the severity of menstrual cramps. Many women using this IUD report significant relief from dysmenorrhea, especially if they previously had severe pain associated with menstruation. D. Pelvic inflammatory disease Levo-Norgestrel-releasing IUDs can actually help reduce the risk of pelvic inflammatory disease (PID). The progestin hormone creates a hostile environment for sperm and pathogens, which can reduce the risk of ascending infections. Although IUDs in general have been historically linked to a small increased risk of PID during the first few weeks after insertion, once placed, these IUDs actually help in preventing infections and reducing the long-term risk of PID.",
      "correct_choice_id": 238582,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/3788191705641864/3788191705641864.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/3788191705641864/3788191705641864.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53366,
      "choices": [
        {
          "id": 238584,
          "text": "Progestrone containing IUCD"
        },
        {
          "id": 238585,
          "text": "Contain desogestrol"
        },
        {
          "id": 238586,
          "text": "Causes endometrial thinning"
        },
        {
          "id": 238587,
          "text": "Decreases menstrual blood flow"
        }
      ],
      "text": "Not true about Mirena",
      "unique_key": "Q6390944",
      "question_audio": null,
      "question_video": null,
      "map_id": 34240891,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Contain desogestrol. Mirena is a progesterone-containing intrauterine device (IUD), but it does not contain desogestrol. Instead, it releases levonorgestrel, which is a synthetic progestin. Levonorgestrel acts locally within the uterus to thin the endometrial lining and reduce menstrual bleeding. Desogestrol is another type of progestin found in some oral contraceptives, but it is not the active ingredient in Mirena. Therefore, this statement is incorrect. Now, let’s look at the incorrect options: A. Progesterone containing IUCD Mirena is indeed a progesterone-containing intrauterine device (IUD). It releases levonorgestrel, a form of progestin, directly into the uterine lining. This hormone helps prevent pregnancy by thickening cervical mucus, inhibiting sperm movement, and thinning the endometrial lining, which reduces the likelihood of implantation. C. Causes endometrial thinning One of the key effects of Mirena is endometrial thinning. The continuous release of levonorgestrel from the device causes the uterine lining to become thinner, which reduces the chances of implantation and also decreases menstrual bleeding. This is one of the reasons why Mirena is effective in treating heavy menstrual bleeding (menorrhagia). D. Decreases menstrual blood flow Mirena decreases menstrual blood flow significantly. Due to the progestin’s effect on the endometrium, women using Mirena often experience lighter periods, and many even stop having periods entirely over time. This is one of the major benefits of the Mirena IUD for women suffering from heavy menstrual bleeding.",
      "correct_choice_id": 238585,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/36141361705641957/36141361705641957.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/36141361705641957/36141361705641957.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53367,
      "choices": [
        {
          "id": 238588,
          "text": "There is increased incidence of menorrhagia"
        },
        {
          "id": 238589,
          "text": "This system can be used as hormone replacement therapy"
        },
        {
          "id": 238590,
          "text": "This method is useful for the treatment of endometrial hyperplasia"
        },
        {
          "id": 238591,
          "text": "Irregular uterine bleeding can be a problem initially"
        }
      ],
      "text": "Which of the following statements is incorrect regarding levonorgestrel releasing intrauterine contraceptive devices:",
      "unique_key": "Q8794563",
      "question_audio": null,
      "question_video": null,
      "map_id": 34620150,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) There is increased incidence of menorrhagia. Levonorgestrel-releasing intrauterine devices (IUDs), such as the Mirena, actually decrease the incidence of menorrhagia (heavy menstrual bleeding), not increase it. The progestin hormone (levonorgestrel) released by the device works by thinning the endometrial lining and reducing menstrual blood flow. Many women using these IUDs experience lighter or even absent periods. Therefore, this statement is incorrect. Now, let’s look at the incorrect options: B. This system can be used as hormone replacement therapy Levonorgestrel-releasing IUDs can be used as a form of hormone replacement therapy (HRT) for women who require progestin, particularly for those who have a uterus. While they are not typically used as a standalone HRT for menopausal symptoms (since they are primarily designed for contraception), they can provide progestin therapy in combination with estrogen for women who are undergoing HRT to protect the endometrium from hyperplasia or cancer. C. This method is useful for the treatment of endometrial hyperplasia Levonorgestrel-releasing IUDs are very effective in treating endometrial hyperplasia (abnormal thickening of the uterine lining). The progestin released by the device helps to thin the endometrial lining and regulate its growth, making it a suitable option for women with endometrial hyperplasia, especially when it is associated with conditions like irregular bleeding. D. Irregular uterine bleeding can be a problem initially It is common for women using a levonorgestrel-releasing IUD to experience irregular uterine bleeding, particularly in the first few months after insertion. This is a normal side effect, as the body adjusts to the hormone release. Many women eventually experience a reduction in bleeding, with some even stopping their periods altogether after prolonged use.",
      "correct_choice_id": 238588,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/65725971705641984/65725971705641984.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/65725971705641984/65725971705641984.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53368,
      "choices": [
        {
          "id": 238592,
          "text": "Reduced retrograde menstruation"
        },
        {
          "id": 238593,
          "text": "Decreased ovulation"
        },
        {
          "id": 238594,
          "text": "Thickened cervical mucus"
        },
        {
          "id": 238595,
          "text": "Decidual changes in the endometrium"
        }
      ],
      "text": "All of the following mechanisms might account for a reduce-risk of upper genital tract infection in users of progestin-releasing IUDs, except :",
      "unique_key": "Q3803672",
      "question_audio": null,
      "question_video": null,
      "map_id": 34334442,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Decreased ovulation. The progestin-releasing IUD does not significantly impact ovulation. The primary mechanism of action for progestin-releasing IUDs, such as the Mirena, involves local effects in the uterus, including the thickening of cervical mucus, endometrial thinning, and changes in the uterine lining. These effects help to reduce the risk of upper genital tract infections by preventing the ascent of bacteria into the uterus and fallopian tubes. However, the IUD does not affect ovulation directly. Therefore, decreased ovulation is not a mechanism that contributes to a reduced risk of infection with progestin-releasing IUDs, making it the incorrect option. Now, let’s look at the other options: A. Reduced retrograde menstruation Progestin-releasing IUDs may reduce retrograde menstruation, which is when menstrual blood flows backward into the pelvic cavity instead of leaving the body. Retrograde menstruation has been linked to an increased risk of pelvic infections, including endometriosis. By reducing retrograde menstruation, progestin-releasing IUDs may lower the risk of pelvic infections, including those in the upper genital tract. C. Thickened cervical mucus One of the primary mechanisms by which progestin-releasing IUDs work is by thickening cervical mucus, making it more difficult for sperm and bacteria to enter the uterus. The thickened mucus acts as a barrier to infection, reducing the likelihood of upper genital tract infections. This is an important protective mechanism provided by the IUD. D. Decidual changes in the endometrium The progestin released by the IUD causes decidual changes in the endometrium, which helps to create a less favorable environment for bacterial growth. These changes in the uterine lining make it less conducive to infection, thereby helping to reduce the risk of upper genital tract infections.",
      "correct_choice_id": 238593,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/67500941705641998/67500941705641998.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/67500941705641998/67500941705641998.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53369,
      "choices": [
        {
          "id": 238596,
          "text": "0.5"
        },
        {
          "id": 238597,
          "text": "1.0"
        },
        {
          "id": 238598,
          "text": "1.5"
        },
        {
          "id": 238599,
          "text": "2.0"
        }
      ],
      "text": "Contraceptive LNG-IUD (levonorgesterel intra-uterine device) has the cumulative pregnancy rate at 5 years of :",
      "unique_key": "Q9005406",
      "question_audio": null,
      "question_video": null,
      "map_id": 34553365,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) 0.5. The levonorgestrel intrauterine device (LNG-IUD) has an extremely low cumulative pregnancy rate, with a failure rate of about 0.5% at 5 years. This makes it one of the most effective reversible contraceptive methods available. The progestin released by the LNG-IUD thickens cervical mucus, prevents sperm from reaching the egg, and thins the endometrial lining, all of which contribute to its high effectiveness in preventing pregnancy. Therefore, the cumulative pregnancy rate at 5 years is very low, around 0.5%. Now, let’s look at the incorrect options: B. 1.0 While the LNG-IUD is very effective, its cumulative pregnancy rate is lower than 1% at 5 years. The rate is around 0.5%, so a 1.0% cumulative pregnancy rate would be too high for this method of contraception. This option is incorrect. C. 1.5 Similarly, a 1.5% cumulative pregnancy rate is also too high for the LNG-IUD. This device is known for its exceptional effectiveness, with pregnancy rates well below 2%, so a 1.5% rate does not align with its actual performance. D. 2.0 A 2.0% pregnancy rate would be far too high for the LNG-IUD, which is one of the most effective forms of contraception available. Its actual cumulative pregnancy rate at 5 years is much lower, around 0.5%. Therefore, this option is also incorrect.",
      "correct_choice_id": 238596,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53370,
      "choices": [
        {
          "id": 238600,
          "text": "Chronic endometrial inflammation"
        },
        {
          "id": 238601,
          "text": "Increase the motility of tubes"
        },
        {
          "id": 238602,
          "text": "Inducing endometrial atrophy"
        },
        {
          "id": 238603,
          "text": "Inhibition of ovulation"
        }
      ],
      "text": "Mechanism by which IUCD does not act;",
      "unique_key": "Q4673134",
      "question_audio": null,
      "question_video": null,
      "map_id": 34701425,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Inhibition of ovulation. Intrauterine contraceptive devices (IUCDs), including both copper and hormone-releasing types (like the Mirena IUD), primarily do not act by inhibiting ovulation. Unlike hormonal contraceptives such as oral pills, which suppress ovulation, IUCDs exert their contraceptive effects through local mechanisms within the uterus, rather than affecting the release of eggs from the ovaries. The primary mechanisms of action of IUCDs involve changes to the uterine environment (e.g., preventing implantation), but they do not reliably prevent ovulation in the same way that methods like the pill do. Therefore, inhibition of ovulation is not a mechanism by which IUCDs work, making this the correct answer. Now, let’s look at the incorrect options: A. Chronic endometrial inflammation Copper IUDs, in particular, cause a chronic inflammatory response in the endometrium, which is toxic to sperm and may also prevent implantation. This inflammatory response makes the uterine lining inhospitable to both sperm and a fertilized egg, effectively preventing pregnancy. This is a well-known mechanism of action for copper IUDs, though it is less significant in hormonal IUDs. B. Increase the motility of tubes IUCDs may also increase the motility of the fallopian tubes, promoting the movement of sperm and eggs. This effect is more pronounced with the copper IUD, which releases copper ions that increase the motility of the fallopian tubes and create a hostile environment for sperm. This can contribute to the contraceptive effect by hindering sperm movement toward the egg. C. Inducing endometrial atrophy Hormonal IUCDs (like the Mirena) release progestin (levonorgestrel), which induces endometrial atrophy. This thinning of the uterine lining makes it less likely for a fertilized egg to implant and develop. Hormonal IUDs, therefore, create an environment where implantation is less likely, and the endometrial atrophy is one of the key mechanisms through which they prevent pregnancy.",
      "correct_choice_id": 238603,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/58120591705642009/58120591705642009.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/58120591705642009/58120591705642009.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53371,
      "choices": [
        {
          "id": 238604,
          "text": "CuT380A"
        },
        {
          "id": 238605,
          "text": "CuT200"
        },
        {
          "id": 238606,
          "text": "Nova T"
        },
        {
          "id": 238607,
          "text": "Multiload"
        }
      ],
      "text": "Among of following IUCD’s which has life span for 10 years :",
      "unique_key": "Q8391249",
      "question_audio": null,
      "question_video": null,
      "map_id": 34189793,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) CuT380A. The CuT380A is an intrauterine contraceptive device (IUCD) that is designed to have a 10-year lifespan. It is one of the most widely used copper IUDs, and its effectiveness extends for up to 10 years. The device releases copper ions into the uterus, creating a hostile environment for sperm and preventing fertilization. Its long lifespan makes it a convenient and effective option for long-term contraception. Now, let’s look at the incorrect options: B. CuT200 The CuT200 is a copper intrauterine device, but it has a 5-year lifespan, not 10 years. While it is effective for contraception, its duration of use is shorter than the CuT380A. After 5 years, it would need to be replaced for continued contraceptive efficacy. C. Nova T The Nova T is another type of copper IUD, and it typically has a 5-year lifespan. It is also effective in preventing pregnancy, but it does not last for 10 years like the CuT380A. The Nova T is designed for shorter-term use compared to the CuT380A. D. Multiload The Multiload is a copper IUD, but it generally has a 5-year lifespan. While it can be used for contraception for several years, it does not last as long as the CuT380A, which is effective for 10 years. Like the CuT200 and Nova T, the Multiload needs to be replaced after 5 years for continued protection.",
      "correct_choice_id": 238604,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/31450631705642027/31450631705642027.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/31450631705642027/31450631705642027.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53372,
      "choices": [
        {
          "id": 238608,
          "text": "MTP"
        },
        {
          "id": 238609,
          "text": "Remove the IUCD"
        },
        {
          "id": 238610,
          "text": "Continue the pregnancy"
        },
        {
          "id": 238611,
          "text": "Remove IUCD and terminate pregnancy"
        }
      ],
      "text": "A lady with IUCD becomes pregnant with tail of IUCD being seen, next course of action is :",
      "unique_key": "Q1401826",
      "question_audio": null,
      "question_video": null,
      "map_id": 34485068,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Remove the IUCD. If a woman with an intrauterine contraceptive device (IUCD) becomes pregnant and the tail of the IUCD is visible, the next course of action is to remove the IUCD. The presence of the IUCD during pregnancy is associated with an increased risk of miscarriage, infection, and preterm labor, so removing it is important as long as it can be done safely without causing harm to the pregnancy. The best outcome for the pregnancy is to remove the IUCD as soon as possible to reduce the risks associated with its presence. Now, let’s look at the incorrect options: A. MTP While medical termination of pregnancy (MTP) may be considered in some situations, it is not the immediate or necessary course of action just because a woman with an IUCD becomes pregnant. The priority is to remove the IUCD first if the pregnancy is ongoing, and then make decisions based on the circumstances. MTP would only be considered if the pregnancy is unviable or if the risks of continuing the pregnancy outweigh the benefits. C. Continue the pregnancy Continuing the pregnancy without removing the IUCD is not recommended. Leaving the IUCD in place during pregnancy significantly increases the risk of complications, including infection, miscarriage, and preterm birth. Therefore, simply continuing the pregnancy without addressing the IUCD is not advised. D. Remove IUCD and terminate pregnancy While removal of the IUCD is necessary, termination of the pregnancy is not required unless there are medical indications or the woman chooses to do so. If the pregnancy is viable and there are no contraindications, the pregnancy can continue after the IUCD is removed. Therefore, termination of pregnancy is not automatically indicated in this scenario.",
      "correct_choice_id": 238609,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/44412941705642509/44412941705642509.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/44412941705642509/44412941705642509.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53373,
      "choices": [
        {
          "id": 238612,
          "text": "Undiagnosed vaginal bleeding"
        },
        {
          "id": 238613,
          "text": "Suspected pregnancy"
        },
        {
          "id": 238614,
          "text": "Congenital malformation of uterus"
        },
        {
          "id": 238615,
          "text": "Active PID"
        }
      ],
      "text": "Absolute contraindication for IUCD includes all of the following except:",
      "unique_key": "Q6456211",
      "question_audio": null,
      "question_video": null,
      "map_id": 34767901,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Congenital malformation of uterus. A congenital malformation of the uterus (such as a bicornuate or septate uterus) is not an absolute contraindication for an IUCD. While these malformations can affect the positioning and placement of an intrauterine contraceptive device (IUCD), they do not automatically rule out the use of an IUD. The healthcare provider may still be able to place the IUCD, though it may require careful monitoring and follow-up. In some cases, malformations can make it more difficult to insert the device or increase the risk of displacement, but it does not constitute an absolute contraindication. Now, let’s look at the incorrect options: A. Undiagnosed vaginal bleeding Undiagnosed vaginal bleeding is an absolute contraindication for IUCD use because it is essential to determine the cause of bleeding before any invasive procedure, such as the insertion of an IUCD. If the bleeding is due to an underlying condition, such as infection, a malignancy, or a uterine abnormality, the IUCD insertion could worsen the situation or complicate treatment. B. Suspected pregnancy Suspected pregnancy is also an absolute contraindication for the use of an IUCD. If a woman is pregnant or suspected to be pregnant, inserting an IUCD could cause harm to the pregnancy, such as miscarriage or infection. It is critical to rule out pregnancy before considering an IUCD as a contraceptive method. D. Active PID (Pelvic Inflammatory Disease) Active PID is a contraindication for IUCD use. Inserting an IUCD in the presence of an active pelvic infection could lead to the spread of infection to the upper reproductive tract, causing severe complications such as infertility, chronic pain, or even sepsis. Therefore, an IUCD should not be inserted during active PID, and treatment of the infection should be prioritized.",
      "correct_choice_id": 238614,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/63503091705642577/63503091705642577.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/63503091705642577/63503091705642577.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53374,
      "choices": [
        {
          "id": 238616,
          "text": "Ectopic pregnancy"
        },
        {
          "id": 238617,
          "text": "Bleeding"
        },
        {
          "id": 238618,
          "text": "Backache"
        },
        {
          "id": 238619,
          "text": "Cervical stenosis"
        }
      ],
      "text": "The most common complication of IUCD is :",
      "unique_key": "Q4515295",
      "question_audio": null,
      "question_video": null,
      "map_id": 34212953,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Bleeding. The most common complication associated with intrauterine contraceptive devices (IUCDs) is bleeding, particularly irregular or heavier menstrual bleeding. Women using IUCDs, especially copper IUDs, may experience increased menstrual flow or spotting between periods, particularly during the first few months after insertion. This is a common side effect and typically improves over time. In some cases, it may be severe enough to cause the woman to seek medical intervention. However, it is usually not dangerous and often resolves once the body adjusts to the presence of the device. Now, let’s look at the incorrect options: A. Ectopic pregnancy While the risk of ectopic pregnancy is increased in women who become pregnant with an IUCD in place (due to the device's failure), it is not the most common complication. The overall failure rate of IUCDs is low, and when a pregnancy does occur, it is more likely to be an intrauterine pregnancy. The risk of an ectopic pregnancy with an IUCD is higher compared to women using other contraceptive methods, but it is still a relatively rare event overall. C. Backache Backache is a less common complication associated with IUCDs. Some women may experience pelvic or back pain after insertion, but this is typically due to the position or placement of the device. Backache is not one of the most frequently reported issues and tends to be less bothersome compared to bleeding. If the backache persists or is severe, it may indicate a problem with the IUCD's position or an infection, and medical consultation is recommended. D. Cervical stenosis Cervical stenosis (narrowing of the cervix) is a rare complication of IUCD insertion. It can occur in certain cases, particularly if there is an issue with the insertion technique or if the woman has a history of cervical scarring (e.g., due to a previous procedure or childbirth). However, cervical stenosis is not a common complication of IUCD use and is considered a more unusual event compared to bleeding.",
      "correct_choice_id": 238617,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/34523041705643034/34523041705643034.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/34523041705643034/34523041705643034.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53375,
      "choices": [
        {
          "id": 238620,
          "text": "Delaying/inhibiting ovulation"
        },
        {
          "id": 238621,
          "text": "Inhibiting fertilization"
        },
        {
          "id": 238622,
          "text": "Preventing implantation of the fertilized egg"
        },
        {
          "id": 238623,
          "text": "Interrupting an early pregnancy"
        }
      ],
      "text": "Emergency contraception prevents pregnancy by all of the following mechanisms, except :",
      "unique_key": "Q1482544",
      "question_audio": null,
      "question_video": null,
      "map_id": 34294577,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Interrupting an early pregnancy. Emergency contraception (EC) does not interrupt an established pregnancy. It works primarily by preventing pregnancy before implantation occurs. EC methods, such as emergency contraceptive pills or the copper IUD, are not designed to terminate an existing pregnancy. Once implantation has occurred, EC methods are ineffective, and the pregnancy will continue. Therefore, the option stating that emergency contraception interrupts an early pregnancy is incorrect. Now, let’s look at the correct mechanisms of emergency contraception: A. Delaying/inhibiting ovulation One of the primary mechanisms of emergency contraception is delaying or inhibiting ovulation. EC works by preventing the release of an egg from the ovary, which prevents fertilization by sperm. This is the most important mechanism for preventing pregnancy, as fertilization cannot occur if there is no egg available for sperm to fertilize. B. Inhibiting fertilization Emergency contraception can also inhibit fertilization by affecting the motility or viability of sperm. By altering the cervical mucus, EC can make it more difficult for sperm to reach and fertilize the egg. This is another way EC helps to prevent pregnancy, although inhibiting ovulation is the primary mechanism. C. Preventing implantation of the fertilized egg Another mechanism of emergency contraception is preventing implantation. If ovulation has occurred and fertilization has taken place, EC can alter the endometrial lining, making it less receptive to the implantation of a fertilized egg. However, this effect is more relevant if EC is taken shortly after unprotected intercourse, and before the fertilized egg reaches the uterus.",
      "correct_choice_id": 238623,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/33865761705643050/33865761705643050.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/33865761705643050/33865761705643050.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53376,
      "choices": [
        {
          "id": 238624,
          "text": "Levonorgestrel"
        },
        {
          "id": 238625,
          "text": "Estrogen + progesterone"
        },
        {
          "id": 238626,
          "text": "Mifepristone"
        },
        {
          "id": 238627,
          "text": "Misoprostol"
        }
      ],
      "text": "Drugs used in emergency contraception are all except",
      "unique_key": "Q9069704",
      "question_audio": null,
      "question_video": null,
      "map_id": 34696629,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Misoprostol. Misoprostol is not used in emergency contraception. While it is used in combination with mifepristone for medical abortion and for inducing labor, it is not a drug used for emergency contraception. Misoprostol works by causing uterine contractions and is typically used in situations where the goal is to expel a pregnancy or induce labor, rather than preventing pregnancy after unprotected intercourse. Now, let's review the drugs used in emergency contraception: A. Levonorgestrel Levonorgestrel is one of the most commonly used drugs in emergency contraception. It is a progestin that works by inhibiting ovulation, delaying fertilization, and preventing implantation of a fertilized egg. Levonorgestrel is available as over-the-counter emergency contraceptive pills (Plan B, Next Choice, etc.) and is effective when taken within 72 hours after unprotected sex. B. Estrogen + progesterone A combination of estrogen and progesterone was historically used in emergency contraception (e.g., the Yuzpe regimen), but it is less commonly used now due to its higher side-effect profile. This regimen involves taking a combination of estrogen and progestin (usually ethinyl estradiol and levonorgestrel) in two doses, within 72 hours of unprotected intercourse. While effective, it can cause more nausea and vomiting compared to progestin-only methods. C. Mifepristone Mifepristone is a progesterone receptor antagonist and can be used in some emergency contraception regimens, although it is more commonly used for medical abortion. It works by blocking the action of progesterone, which is necessary for maintaining a pregnancy. When used in high doses, it can prevent pregnancy, but it is generally not the first-line treatment for emergency contraception. However, it can be used off-label as an emergency contraceptive.",
      "correct_choice_id": 238627,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/23263881705643061/23263881705643061.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/23263881705643061/23263881705643061.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53377,
      "choices": [
        {
          "id": 238628,
          "text": "IUCD"
        },
        {
          "id": 238629,
          "text": "Depoprovera"
        },
        {
          "id": 238630,
          "text": "Diaphragm"
        },
        {
          "id": 238631,
          "text": "Oral contraceptive pills"
        }
      ],
      "text": "Which one of the following is the ideal contraceptive for a patient with heart disease:",
      "unique_key": "Q3883768",
      "question_audio": null,
      "question_video": null,
      "map_id": 34817171,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) IUCD (Intrauterine Contraceptive Device). For patients with heart disease, the ideal contraceptive is the IUCD, particularly a copper IUD or levonorgestrel-releasing IUD (Mirena). This is because the IUCD does not involve hormones that could exacerbate heart conditions. Unlike hormonal contraceptives, which may increase the risk of thromboembolism, an IUCD is a non-hormonal method that provides effective, long-term contraception without affecting the cardiovascular system. It also does not have systemic side effects, making it a safe choice for women with heart disease. Now, let’s discuss why the other options are less ideal for patients with heart disease: B. Depoprovera (Depo-Provera) Depo-Provera, or the injectable progestin-only contraceptive, is not ideal for women with heart disease. While it is effective, progestin-only methods can increase the risk of thromboembolic events, which can be particularly dangerous for women with pre-existing heart conditions. Additionally, Depo-Provera can lead to weight gain and bone density loss over time, which are undesirable side effects. While it may be used in some cases, it is generally less preferred for patients with heart disease. C. Diaphragm The diaphragm is a barrier method of contraception and does not have direct effects on the cardiovascular system. However, it requires correct and consistent use, and there is no hormonal component involved. While it is relatively safe, it is less effective than other contraceptive methods (such as the IUD) and may not be the most reliable option for women who have heart disease and need a highly effective form of contraception. D. Oral contraceptive pills Oral contraceptive pills (OCPs), particularly combined oral contraceptives (which contain both estrogen and progestin), are generally contraindicated in women with heart disease, especially if they have a history of hypertension, stroke, or venous thromboembolism. Estrogen can increase the risk of blood clots, which can be especially dangerous for women with heart conditions. Progestin-only pills are considered safer for women with cardiovascular disease but are still not the first choice compared to non-hormonal methods like the IUCD.",
      "correct_choice_id": 238628,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/10377901705643088/10377901705643088.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/10377901705643088/10377901705643088.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53378,
      "choices": [
        {
          "id": 238632,
          "text": "OCPs"
        },
        {
          "id": 238633,
          "text": "Condoms"
        },
        {
          "id": 238634,
          "text": "IUCD"
        },
        {
          "id": 238635,
          "text": "Diaphragm"
        }
      ],
      "text": "PID occurs least common with;",
      "unique_key": "Q3774834",
      "question_audio": null,
      "question_video": null,
      "map_id": 34897931,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Condoms. Condoms provide the least risk of pelvic inflammatory disease (PID). This is because condoms are a barrier method that physically prevent the transmission of sexually transmitted infections (STIs), which are the primary cause of PID. By reducing the risk of STIs, condoms directly help in preventing the infection that could lead to PID. Thus, they are an effective contraceptive in reducing the risk of PID. Let’s look at why the other options have a higher association with PID: A. OCPs (Oral Contraceptive Pills) Oral contraceptive pills (OCPs) reduce the risk of PID by suppressing ovulation and decreasing the likelihood of the formation of conditions like endometrial infection. However, while they reduce some risks, OCPs do not directly protect against sexually transmitted infections (STIs), which are the main risk factor for PID. Therefore, while OCPs can indirectly lower the risk, they don’t provide the direct protection against infection that condoms do. C. IUCD (Intrauterine Contraceptive Device) The IUCD has a higher association with PID, especially in the first few months after insertion. The risk is especially high for women who already have an untreated STI at the time of insertion. The presence of an IUCD may provide a pathway for infection to ascend into the uterus, causing PID. Therefore, while the IUCD is an effective long-term contraceptive method, it carries a greater risk for PID compared to condoms. D. Diaphragm The diaphragm, like the IUCD, does not protect against sexually transmitted infections (STIs), and its use has been linked to an increased risk of developing PID in some studies. The diaphragm may also increase the risk of UTIs (urinary tract infections), which could indirectly contribute to the development of PID. While it is a barrier method, it is less effective than condoms in preventing PID due to its inability to protect against STIs.",
      "correct_choice_id": 238633,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/52813831705643099/52813831705643099.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/52813831705643099/52813831705643099.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53379,
      "choices": [
        {
          "id": 238636,
          "text": "Barrier method"
        },
        {
          "id": 238637,
          "text": "Combined OCP"
        },
        {
          "id": 238638,
          "text": "IUCD"
        },
        {
          "id": 238639,
          "text": "Progesterone only pill"
        }
      ],
      "text": "Ideal contraceptive for newely married couple is:",
      "unique_key": "Q3353845",
      "question_audio": null,
      "question_video": null,
      "map_id": 34784789,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Combined OCP (Oral Contraceptive Pills). For a newly married couple, the combined oral contraceptive pill (OCP) is often considered the ideal contraceptive method due to several reasons. Combined OCPs contain both estrogen and progestin, which effectively prevent pregnancy by inhibiting ovulation, thickening cervical mucus, and altering the endometrium to prevent implantation. This method is highly effective when used correctly and offers the added benefit of regulating menstrual cycles and reducing menstrual cramps. It is also a reversible form of contraception, which means fertility typically returns soon after discontinuation, making it ideal for couples who may wish to conceive in the future. Additionally, combined OCPs are easy to use and do not require long-term commitment, which is often appealing to newly married couples. Let’s now discuss why the other options are less ideal for newly married couples: A. Barrier Method The barrier method (such as condoms) can be effective at preventing pregnancy and also helps prevent sexually transmitted infections (STIs). However, barrier methods, while good for temporary contraception, tend to have a lower efficacy compared to hormonal methods like the combined OCP. Many couples may also find barrier methods less convenient, and the lack of spontaneity and the requirement for use every time may make this method less appealing for a newly married couple seeking a long-term, convenient solution. C. IUCD (Intrauterine Contraceptive Device) The IUCD is a highly effective long-term contraceptive method but may not be the first choice for a newly married couple, especially if they are not yet certain about their family planning desires. Insertion of an IUCD requires a medical procedure, and there may be concerns about discomfort, side effects like bleeding irregularities, and potential risks such as infection in the first few weeks after insertion. The IUCD is also more appropriate for women who are done with childbearing or have had children before, as it is designed for long-term use (5-10 years). D. Progesterone Only Pill The progesterone-only pill (also known as the mini-pill) is a good option for women who cannot take estrogen or those who are breastfeeding. However, it is generally less effective than the combined OCP and requires strict adherence to the same time every day. The progesterone-only pill also does not offer the added benefits of menstrual regulation or reduced cramping that come with combined OCPs. For a newly married couple who is likely looking for a reliable, convenient contraceptive method, the combined OCP is often the better choice.",
      "correct_choice_id": 238637,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53380,
      "choices": [
        {
          "id": 238640,
          "text": "Barrier method"
        },
        {
          "id": 238641,
          "text": "IUCD"
        },
        {
          "id": 238642,
          "text": "OCP"
        },
        {
          "id": 238643,
          "text": "DMPA"
        }
      ],
      "text": "Ideal contraceptive for a couple living in different cities meeting only occasionally :",
      "unique_key": "Q8007976",
      "question_audio": null,
      "question_video": null,
      "map_id": 34809465,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Barrier method. For a couple living in different cities and meeting only occasionally, the barrier method, such as condoms, is often the ideal contraceptive choice. This is because the barrier method is easy to use, does not require frequent visits to a healthcare provider, and is available over the counter. It can be used only when needed, providing flexibility for a couple who is not in a regular, daily physical relationship. Additionally, condoms are highly effective in preventing sexually transmitted infections (STIs), which is important when partners are not regularly together and may have concerns about sexual health during occasional meetings. Now let’s explore why the other options may not be ideal for this situation: B. IUCD (Intrauterine Contraceptive Device) The IUCD is a long-term contraceptive that needs to be inserted by a healthcare professional and can stay in place for several years. While it is a highly effective option, it is not suitable for a couple that has intermittent sexual activity. The IUCD requires a medical procedure for insertion and removal, making it less flexible and inconvenient for a couple who is not together regularly. It is also intended more for women who are in a stable, long-term relationship and want long-term contraception. C. OCP (Oral Contraceptive Pills) The combined oral contraceptive pill (OCP) requires daily use to be effective, making it a less suitable option for a couple that is not together regularly. If the woman in the relationship misses a pill or is inconsistent with the schedule due to occasional meetings, the efficacy of the pill could be compromised. Additionally, OCPs require a prescription and regular refills, which may be inconvenient for someone with irregular sexual activity and an irregular schedule. D. DMPA (Depot Medroxyprogesterone Acetate) DMPA is a long-acting injectable contraceptive that requires an injection every three months. While it is highly effective, it might not be ideal for a couple with infrequent meetings, as the timing of injections needs to be maintained for continued effectiveness. If the couple is not meeting consistently every three months, the woman may miss the scheduled injection, and this could lead to a loss of contraceptive efficacy.",
      "correct_choice_id": 238640,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/23875651705643127/23875651705643127.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/23875651705643127/23875651705643127.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53381,
      "choices": [
        {
          "id": 238644,
          "text": "Barrier method"
        },
        {
          "id": 238645,
          "text": "Combined OCP"
        },
        {
          "id": 238646,
          "text": "Lactational amenorrhoea"
        },
        {
          "id": 238647,
          "text": "Progesterone only pill"
        }
      ],
      "text": "Ideal contraceptive for lactating mother is:",
      "unique_key": "Q5149504",
      "question_audio": null,
      "question_video": null,
      "map_id": 34579492,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Progesterone only pill. For a lactating mother, the progesterone-only pill (POP) is the ideal contraceptive choice. The POP contains only progesterone and is safe for breastfeeding mothers because it does not affect milk production. Unlike combined oral contraceptives, which contain both estrogen and progesterone, the progesterone-only pill does not interfere with lactation and is suitable during the postpartum period, even when a mother is exclusively breastfeeding. This pill is also highly effective when taken correctly and has a low risk of side effects for breastfeeding women. Let’s now discuss why the other options are less suitable for a lactating mother: A. Barrier method The barrier method, such as condoms, is a safe and effective option, but it may not be the most convenient or ideal method for a lactating mother. While it doesn't interfere with breastfeeding and provides protection against sexually transmitted infections (STIs), barrier methods are less effective than hormonal methods like the POP in preventing pregnancy and require use during every act of intercourse. Many couples find the barrier method less convenient, especially when other more reliable contraceptive options are available. B. Combined OCP Combined oral contraceptives (OCPs), which contain both estrogen and progesterone, are not recommended for lactating mothers because the estrogen component can reduce milk production. Estrogen can also lead to early weaning or a reduction in the amount of milk produced, which can be problematic for breastfeeding mothers. Therefore, combined OCPs are typically not advised during the first 6 months postpartum, when breastfeeding is most critical. C. Lactational amenorrhea The lactational amenorrhea method (LAM) is based on the natural infertility that occurs when a mother is exclusively breastfeeding. While this method can be effective in the first 6 months postpartum, it is not a reliable long-term contraceptive because its effectiveness depends on several factors, including the frequency of breastfeeding, the infant's age, and the mother’s hormonal changes. Once a mother begins supplementing with other foods or her periods resume, the effectiveness of LAM decreases. As a result, the progesterone-only pill is a more consistent and reliable choice for contraception.",
      "correct_choice_id": 238647,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/16204801705643141/16204801705643141.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/16204801705643141/16204801705643141.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53382,
      "choices": [
        {
          "id": 238648,
          "text": "Raloxifene"
        },
        {
          "id": 238649,
          "text": "Ormeloxifene"
        },
        {
          "id": 238650,
          "text": "Clomifene"
        },
        {
          "id": 238651,
          "text": "Toremifene"
        }
      ],
      "text": "SERM used for contraception :",
      "unique_key": "Q1493808",
      "question_audio": null,
      "question_video": null,
      "map_id": 34014123,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Ormeloxifene. Ormeloxifene is a selective estrogen receptor modulator (SERM) that is used for contraception. It works by acting on the estrogen receptors in the reproductive system to prevent ovulation, alter the endometrial lining, and thicken cervical mucus, all of which contribute to preventing pregnancy. Ormeloxifene is marketed as a non-hormonal contraceptive and is typically taken as a weekly pill. It is a relatively newer and less common contraceptive method but has been proven effective in preventing pregnancy. Now, let’s review why the other options are not suitable for contraception: A. Raloxifene Raloxifene is a SERM primarily used for the treatment and prevention of osteoporosis in postmenopausal women and to reduce the risk of breast cancer. While it acts as an estrogen agonist in bone tissue, it does not have contraceptive effects and is not used for birth control. It is not approved or recommended for contraception. C. Clomifene Clomifene (or clomiphene citrate) is a SERM that is primarily used to induce ovulation in women who have anovulatory infertility. It works by stimulating the release of gonadotropins to induce ovulation, making it useful for fertility treatments. However, it is not used for contraception and actually helps women become pregnant, not prevent it. D. Toremifene Toremifene is another SERM used primarily for the treatment of breast cancer in postmenopausal women. Like raloxifene, it has no contraceptive effect and is not used for birth control purposes. Toremifene works as an estrogen antagonist in breast tissue but does not have the same action on the reproductive system as ormeloxifene does for contraception.",
      "correct_choice_id": 238649,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/3381701705643152/3381701705643152.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/3381701705643152/3381701705643152.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53383,
      "choices": [
        {
          "id": 238652,
          "text": "Hormonal method"
        },
        {
          "id": 238653,
          "text": "Baimer method"
        },
        {
          "id": 238654,
          "text": "Behavioral method"
        },
        {
          "id": 238655,
          "text": "LARC method"
        }
      ],
      "text": "Billings method of contraception is a _____",
      "unique_key": "Q9046002",
      "question_audio": null,
      "question_video": null,
      "map_id": 34253151,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Behavioral method. The Billings method of contraception is a behavioral method based on monitoring changes in cervical mucus during the menstrual cycle. By tracking the pattern and consistency of cervical mucus, a woman can identify the fertile and infertile periods of her cycle and avoid unprotected intercourse during the fertile window, thus preventing pregnancy. The Billings method does not involve the use of any hormones, devices, or medical interventions, making it a natural form of contraception. It relies on the understanding and interpretation of natural bodily signs, making it an ideal choice for those who prefer to avoid hormonal methods or physical devices. Now let’s look at why the other options are incorrect: A. Hormonal method The Billings method does not use hormonal interventions. Hormonal methods include options such as oral contraceptives (birth control pills), hormonal IUDs, and implants, which release hormones like estrogen and progesterone to prevent pregnancy. The Billings method is natural and non-hormonal, so this option is incorrect. B. Baimer method There is no such method called the \"Baimer method.\" This is likely a typographical error or misunderstanding of another term. The Billings method is unrelated to any method by this name, making this option incorrect. D. LARC method LARC (Long-Acting Reversible Contraception) methods, such as the IUD or contraceptive implants, involve the use of physical devices or implants that provide long-term contraception without daily intervention. These methods are highly effective, but the Billings method does not involve any physical device or implant. Therefore, the Billings method is not classified as a LARC method.",
      "correct_choice_id": 238654,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/51762031705643164/51762031705643164.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/51762031705643164/51762031705643164.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53384,
      "choices": [
        {
          "id": 238656,
          "text": "Mirena"
        },
        {
          "id": 238657,
          "text": "Implanon"
        },
        {
          "id": 238658,
          "text": "OCP"
        },
        {
          "id": 238659,
          "text": "DMPA"
        }
      ],
      "text": "Contraception with least failure rate:",
      "unique_key": "Q1921454",
      "question_audio": null,
      "question_video": null,
      "map_id": 34565168,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Implanon. Implanon, also known as subdermal contraceptive implants, has the least failure rate among the options listed. Implanon is a long-acting reversible contraceptive (LARC) that involves the implantation of a small, flexible rod under the skin of the upper arm. It releases a steady dose of etonogestrel, a progestin hormone, which prevents pregnancy by inhibiting ovulation, thickening cervical mucus, and altering the endometrial lining. Implanon is highly effective, with a failure rate of less than 1%, making it one of the most reliable forms of contraception. Its failure rate is very low because once implanted, it works for up to 3 years without requiring any daily action from the user. Now, let's examine the other options: A. Mirena The Mirena IUD is a hormonal intrauterine device that releases levonorgestrel to prevent pregnancy. While Mirena is very effective, with a failure rate of around 0.2%, it is slightly higher than the Implanon implant. Mirena is a long-acting reversible contraceptive and is highly reliable, but the Implanon implant is considered to have the lowest failure rate because it doesn't involve any potential for user error (like with the IUD placement or potential expulsion of the IUD). C. OCP (Oral Contraceptive Pills) Oral contraceptive pills, while highly effective when taken correctly, have a higher failure rate than long-acting methods like Implanon or Mirena. The failure rate of oral contraceptive pills is about 9% with typical use, largely due to human error, such as forgetting to take the pill or taking it at inconsistent times. The failure rate is lower with perfect use, but still higher than the more consistent, long-acting methods. D. DMPA (Depo-Provera) DMPA is an injectable form of contraception that provides 3 months of protection against pregnancy. While it is effective, with a failure rate of about 4% with typical use, it is still not as effective as Implanon. The failure rate can be slightly higher due to the need for timely injections, and missed appointments can increase the risk of pregnancy. However, like the Mirena, it is still a highly effective method compared to other non-LARC methods.",
      "correct_choice_id": 238657,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/47065261705643174/47065261705643174.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/47065261705643174/47065261705643174.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53385,
      "choices": [
        {
          "id": 238660,
          "text": "Decreases incidence of Breast CA"
        },
        {
          "id": 238661,
          "text": "Decreases incidence of lung CA"
        },
        {
          "id": 238662,
          "text": "Decreases incidence of colorectal CA"
        },
        {
          "id": 238663,
          "text": "Decreases incidence of Gallbladder CA"
        }
      ],
      "text": "Which of the following is the noncontraceptive benefit of OCP'S?",
      "unique_key": "Q7261409",
      "question_audio": null,
      "question_video": null,
      "map_id": 34780102,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Decreases incidence of colorectal cancer. Oral contraceptive pills (OCPs) have several non-contraceptive benefits, one of which is the reduction in the incidence of certain types of cancer, including colorectal cancer. Studies have shown that long-term use of OCPs can significantly decrease the risk of colorectal cancer, likely due to the effects of the hormones in the pills on cell growth and differentiation. This protective effect can last for many years even after stopping the use of OCPs. The exact mechanisms are still under study, but hormonal modulation of growth factors and reduced ovulatory cycles are believed to play a role in decreasing the risk. Now, let's look at why the other options are incorrect: A. Decreases incidence of Breast Cancer In fact, OCPs are associated with a slightly increased risk of breast cancer during use. The risk is typically higher in women who use OCPs at a younger age or for a prolonged period. However, this risk seems to diminish after stopping OCP use, and overall, the increased risk is relatively small compared to the benefits OCPs offer in terms of reducing risks for other cancers like ovarian and endometrial cancers. B. Decreases incidence of lung cancer There is no evidence that OCP use decreases the incidence of lung cancer. In fact, the hormonal influences on lung tissue are not well understood, but OCPs do not appear to have a protective effect against lung cancer. Some studies have suggested that hormonal therapy may increase the risk of certain cancers, but lung cancer is not one of those for which OCPs offer protection. D. Decreases incidence of Gallbladder Cancer OCPs do not appear to decrease the incidence of gallbladder cancer. In fact, OCP use has been associated with an increased risk of gallbladder disease, including gallstones. Hormonal changes caused by OCPs may affect bile composition, leading to an increased likelihood of gallstone formation, which can lead to cholecystitis or other gallbladder-related issues, but it does not protect against gallbladder cancer.",
      "correct_choice_id": 238662,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/53259131705643188/53259131705643188.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/53259131705643188/53259131705643188.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53386,
      "choices": [
        {
          "id": 238664,
          "text": "15 mcg/d"
        },
        {
          "id": 238665,
          "text": "50 mcg/d"
        },
        {
          "id": 238666,
          "text": "8 mcg/d"
        },
        {
          "id": 238667,
          "text": "120 mcg/d"
        }
      ],
      "text": "What is the release rate of etonogestrel from NUVA Ring?",
      "unique_key": "Q7909513",
      "question_audio": null,
      "question_video": null,
      "map_id": 34827048,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D)<p><img src=\"https://d2enu63wt1sf3u.cloudfront.net/course_file_meta/1062381ans.849.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 238667,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53387,
      "choices": [
        {
          "id": 238668,
          "text": "IUCD"
        },
        {
          "id": 238669,
          "text": "DMPA"
        },
        {
          "id": 238670,
          "text": "POPs"
        },
        {
          "id": 238671,
          "text": "Implanon"
        }
      ],
      "text": "All of the following are LARC methods except:",
      "unique_key": "Q3222430",
      "question_audio": null,
      "question_video": null,
      "map_id": 34494460,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) POPs (Progestin-Only Pills). Long-Acting Reversible Contraceptives (LARCs) are methods that provide effective contraception for an extended period of time with minimal maintenance or intervention. POPs are not classified as a LARC method because they require daily use and do not have the prolonged, set-and-forget nature of LARC methods. POPs must be taken consistently and are less convenient for long-term use compared to LARCs. Here's why the other options are incorrect: A. IUCD (Intrauterine Copper Device) The IUCD is a LARC because it is a long-acting device placed in the uterus that can prevent pregnancy for several years (up to 10 years or more depending on the type). It is a highly effective, low-maintenance option for long-term contraception. B. DMPA (Depot Medroxyprogesterone Acetate) DMPA is a LARC method. It is an injectable form of contraception that is administered every 3 months, providing long-term protection without the need for daily attention or action by the user. D. Implanon Implanon is a LARC method. It is a small, flexible implant placed under the skin of the upper arm and releases hormones for up to 3 years, providing long-lasting protection without the need for daily attention.",
      "correct_choice_id": 238670,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53388,
      "choices": [
        {
          "id": 238672,
          "text": "Dilate the cervix and explore the uterus under general anaesthesia"
        },
        {
          "id": 238673,
          "text": "Perform a CT scan"
        },
        {
          "id": 238674,
          "text": "Perform a transvaginal ultrasound scan"
        },
        {
          "id": 238675,
          "text": "Perform an X-ray of the pelvis"
        }
      ],
      "text": "Women who had an IUCD inserted 1 year ago attends the clinic for a routine checkup. On vaginal examination the threads of the IUCD are not found. Attempts to retrieve threads using a cervical cytology brush failed. What is the next step in the management?",
      "unique_key": "Q5943500",
      "question_audio": null,
      "question_video": null,
      "map_id": 34218830,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Perform a transvaginal ultrasound scan. A transvaginal ultrasound scan is the most appropriate next step when the threads of an IUCD cannot be found during a vaginal examination, and attempts to retrieve them have failed. This method is non-invasive and highly effective for locating the position of the IUCD, whether it is in the uterus or if it has perforated the uterine wall or migrated into the abdominal cavity. The ultrasound will allow the healthcare provider to confirm the presence, position, and any potential complications related to the IUCD. Here's why the other options are incorrect: A. Dilate the cervix and explore the uterus under general anaesthesia This approach may be necessary if the IUCD cannot be located through non-invasive methods, but it is not the first step. Exploring the uterus under general anaesthesia would be considered if imaging methods like ultrasound have not provided sufficient information. This is a more invasive and riskier option that should be avoided unless absolutely necessary. B. Perform a CT scan A CT scan is not typically the first choice for investigating the location of an IUCD. It exposes the patient to unnecessary radiation and may not provide as clear or detailed a view of the device's location in the uterus compared to ultrasound, which is the gold standard for imaging soft tissues and the reproductive organs. D. Perform an X-ray of the pelvis X-rays can sometimes be helpful in locating a displaced IUCD, especially if it is made of metal. However, ultrasound is the preferred initial imaging technique as it provides real-time, detailed images and does not expose the patient to unnecessary radiation. X-rays are generally not as effective in identifying soft tissue or detecting complications like perforation or migration of the IUCD.",
      "correct_choice_id": 238674,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53389,
      "choices": [
        {
          "id": 238676,
          "text": "It's unrelated to OCPs"
        },
        {
          "id": 238677,
          "text": "It may fade away with time"
        },
        {
          "id": 238678,
          "text": "It might exacerbate with next pregnancy"
        },
        {
          "id": 238679,
          "text": "Need other endocrinal evaluation tests"
        }
      ],
      "text": "A 40yr lady with brown patches on her skin (chin, cheeks, forehead). She's not on any regular medication except birth control pills. She has observed that it has increased after 1st delivery and also after the 2nd delivery. Thyroid function test is normal. Which statement is correct?",
      "unique_key": "Q5369835",
      "question_audio": null,
      "question_video": null,
      "map_id": 34107640,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) It might exacerbate with next pregnancy. The description of brown patches on the skin, particularly on areas such as the chin, cheeks, and forehead, is characteristic of melasma. Melasma is a common skin condition often seen in women, especially during pregnancy (referred to as the \"mask of pregnancy\") or while using oral contraceptive pills (OCPs). The hormonal changes that occur during pregnancy, particularly the increased levels of estrogen and progesterone, can trigger the development or worsening of melasma. Given that the patient reports the condition increased after her first and second deliveries, it is likely that her melasma is hormone-related. As pregnancy involves further hormonal changes, there is a strong possibility that the condition may worsen with subsequent pregnancies. Here's why the other options are incorrect: A. It's unrelated to OCPs This statement is incorrect. OCPs are well known to be a contributing factor in the development of melasma. The increased levels of estrogen and progesterone from the hormonal contraceptives can stimulate the melanocytes (skin cells responsible for pigment production), leading to the characteristic brown patches on the skin. Given that the patient is on birth control pills, it's highly likely that the OCPs are a contributing factor. B. It may fade away with time While melasma can sometimes fade over time, it does not always do so, especially if the triggering factor, such as hormonal changes due to OCPs or pregnancy, remains present. In fact, in many cases, melasma persists as long as the hormonal influence continues. Discontinuing birth control pills may reduce the severity in some cases, but the patches might not completely fade without treatment. Therefore, it’s not guaranteed that the condition will fade away with time. D. Need other endocrinal evaluation tests This is not necessary because the patient’s thyroid function tests are normal. Melasma is typically associated with hormonal changes from pregnancy or the use of hormonal contraceptives, and there is no indication of an underlying endocrine disorder in this case. Additional endocrine testing is not indicated unless other symptoms suggest a thyroid or other hormonal imbalance, which does not appear to be the case here.",
      "correct_choice_id": 238678,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53390,
      "choices": [
        {
          "id": 238680,
          "text": "Intrauterine device"
        },
        {
          "id": 238681,
          "text": "Laparoscopic bilateral tubal ligation"
        },
        {
          "id": 238682,
          "text": "Combination oral contraceptives"
        },
        {
          "id": 238683,
          "text": "Diaphragm"
        },
        {
          "id": 238684,
          "text": "Transdermal patch"
        }
      ],
      "text": "A 42-year-old G4P3104 presents for her well-woman examination. She has had three vaginal deliveries and one cesarean delivery for breech. She states her cycles are regular and denies any sexually transmi?ed diseases. Currently she and her husband use condoms, but they hate the hassle of a coital-dependent method. She is interested in a more effective contraception because they do not want any more children. She reports occasional migraine headaches and had a serious allergic reaction to anaesthesia as a child when she underwent a tonsillectomy. She drinks and smokes socially. She weighs 78 kg, and her blood pressure is 142/89 mm Hg. During her office visit, you counsel the patient at length regarding birth control methods. Which of the following is the most appropriate contraceptive method for this patient?",
      "unique_key": "Q2721723",
      "question_audio": null,
      "question_video": null,
      "map_id": 34710108,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Intrauterine device. An Intrauterine device (IUD), particularly a Copper IUD or Levonorgestrel-releasing IUD, is the most appropriate contraceptive method for this patient based on her medical history and current circumstances. IUDs are highly effective, long-acting, and reversible, and they do not require daily attention, making them ideal for patients who want a hassle-free and reliable method of contraception. Given that this patient has regular cycles, does not want more children, and has a relatively high body mass index (BMI), IUDs are safe and provide long-term contraception without the potential side effects associated with other hormonal methods like combined oral contraceptives. Additionally, her blood pressure is elevated (142/89 mm Hg), which would make combined hormonal methods like oral contraceptives less ideal due to the potential cardiovascular risks associated with estrogen. Explanation for the incorrect options: B. Laparoscopic bilateral tubal ligation Bilateral tubal ligation is a permanent method of contraception and would not be the first choice for a patient who is still of reproductive age and may change her mind about future fertility. Even though the patient does not want more children, tubal ligation should be considered only when a woman is absolutely certain about not wanting more children. It is a surgical procedure that carries risks and is more invasive than a non-surgical, reversible option like an IUD. C. Combination oral contraceptives This method involves taking hormonal contraceptives that contain both estrogen and progestin. Given the patient's elevated blood pressure (142/89 mm Hg), this is a less appropriate choice because estrogen-containing contraceptives can increase the risk of thromboembolic events and other cardiovascular complications. The patient’s occasional migraine headaches, particularly if they are with aura, further increase the risk of stroke with estrogen-containing methods. As such, combined oral contraceptives are not ideal for her. D. Diaphragm While a diaphragm is a non-hormonal contraceptive option, it is not as effective as an IUD, especially in a woman who desires a more reliable, coital-independent method of contraception. The diaphragm requires correct placement before each act of intercourse and needs to be used with spermicide. It also requires consistent maintenance and can be cumbersome, making it less desirable for women who are looking for a more permanent and less hassle-prone method. E. Transdermal patch The transdermal patch delivers hormones (estrogen and progestin) through the skin, similar to combination oral contraceptives. This method also has the drawback of including estrogen, which is not recommended for women with elevated blood pressure like this patient. Moreover, the patch may be less effective in women who weigh over 90 kg (198 lbs), which could be a consideration for this patient, given her weight of 78 kg. However, the patch is still less ideal compared to an IUD.",
      "correct_choice_id": 238680,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53391,
      "choices": [
        {
          "id": 238685,
          "text": "Intrauterine device"
        },
        {
          "id": 238686,
          "text": "Laparoscopic bilateral tubal ligation"
        },
        {
          "id": 238687,
          "text": "Combination oral contraceptives"
        },
        {
          "id": 238688,
          "text": "Transdermal patch"
        }
      ],
      "text": "A 42-year-old woman has had three vaginal deliveries and one caesarean delivery for breech. Currently she and her husband use condoms but She is interested in a more e?ective contraception She reports occasional migraine headaches and had a serious allergic reaction to anaesthesia as a child when she underwent a tonsillectomy. She weighs 78 kg, and her blood pressure is 142/89 mm Hg. Which of the following is the most appropriate contraceptive method for this patient?",
      "unique_key": "Q9545297",
      "question_audio": null,
      "question_video": null,
      "map_id": 34368642,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Intrauterine device (IUD). An Intrauterine device (IUD), particularly the Levonorgestrel-releasing IUD or the Copper IUD, is the most appropriate choice for this patient. IUDs are highly effective, long-lasting, reversible, and do not rely on daily adherence like oral contraceptives. Given her elevated blood pressure (142/89 mm Hg), combined hormonal methods such as oral contraceptives or the transdermal patch would not be the best choice due to potential cardiovascular risks associated with estrogen. Additionally, IUDs are well-tolerated by most women and provide effective contraception without interfering with lactation or daily routines. They are also suitable for women who no longer want children but do not want permanent sterilization. Explanation for the incorrect options: B. Laparoscopic bilateral tubal ligation Bilateral tubal ligation is a permanent method of contraception and is generally considered only when a woman is absolutely certain that she does not want more children. While it is an effective method, it is a surgical procedure with inherent risks. For a woman who may still consider having children in the future, or one who prefers a non-permanent option, the IUD (which is reversible) would be a better choice. C. Combination oral contraceptives This method involves taking hormones (estrogen and progestin), which would increase the patient's risk for thromboembolic events, particularly with her elevated blood pressure of 142/89 mm Hg. Women with hypertension or other cardiovascular risk factors should avoid estrogen-containing contraceptives, as estrogen can exacerbate these risks. In this case, the patient’s blood pressure contraindicates the use of combination oral contraceptives. D. Transdermal patch Like combination oral contraceptives, the transdermal patch also contains estrogen. It can increase the risk of blood clots and other cardiovascular events, especially in women with elevated blood pressure. Additionally, the patch might be less effective in women with a higher body mass index (BMI), and it is not ideal for someone with her current health status. The IUD, being non-hormonal or using a local hormone (levonorgestrel), is safer and more effective for this patient.",
      "correct_choice_id": 238685,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53392,
      "choices": [
        {
          "id": 238689,
          "text": "Perforation of uterus"
        },
        {
          "id": 238690,
          "text": "Cyclical menstrual bleeding"
        },
        {
          "id": 238691,
          "text": "Flaring up of salpingitis"
        },
        {
          "id": 238692,
          "text": "Pregnancy with IUD"
        }
      ],
      "text": "Indications for removal of IUD are all except",
      "unique_key": "Q4505495",
      "question_audio": null,
      "question_video": null,
      "map_id": 34507197,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Cyclical menstrual bleeding. Cyclical menstrual bleeding is not an indication for the removal of an IUD. In fact, many users of the IUD experience changes in their menstrual bleeding patterns, including lighter periods or even the cessation of menstruation, particularly with hormonal IUDs. This change is usually not harmful, and therefore does not necessitate the removal of the device. Cyclical bleeding is a normal occurrence in most cases and does not require any intervention unless it becomes excessively heavy or bothersome. Explanation for the incorrect options: A. Perforation of uterus Perforation of the uterus is a serious complication that can occur during IUD insertion, where the device may puncture the uterine wall. If this happens, the IUD needs to be removed to prevent further injury and potential complications such as infection, bleeding, or damage to other internal organs. If perforation is suspected, the IUD must be removed. C. Flaring up of salpingitis Salpingitis is an infection of the fallopian tubes, often caused by pelvic inflammatory disease (PID). An IUD, particularly during the first few weeks after insertion, can increase the risk of PID if there is a pre-existing infection or if infection occurs due to the IUD. If a woman experiences a flare-up of salpingitis, it is necessary to remove the IUD to prevent further infection and complications, including infertility. D. Pregnancy with IUD If a woman becomes pregnant while using an IUD, it is an indication for removal of the device. Pregnancy with an IUD increases the risk of ectopic pregnancy (a pregnancy outside the uterus), miscarriage, and infection. Therefore, the IUD should be removed as soon as a pregnancy is confirmed, unless it is impossible to do so safely (e.g., if the pregnancy is too advanced or if removal poses significant risk).",
      "correct_choice_id": 238690,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53393,
      "choices": [
        {
          "id": 238693,
          "text": "Immediately after intercourse"
        },
        {
          "id": 238694,
          "text": "1 hour after intercourse"
        },
        {
          "id": 238695,
          "text": "6 hours after intercourse"
        },
        {
          "id": 238696,
          "text": "12 hours after intercourse"
        }
      ],
      "text": "32-year-old woman was fitted for a diaphragm earlier in the day. She asks the physician when the diaphragm should be removed from the vagina after intercourse. Which of the following is that correct response?",
      "unique_key": "Q6877766",
      "question_audio": null,
      "question_video": null,
      "map_id": 34785430,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) 6 hours after intercourse. A diaphragm should be left in place for at least 6 hours after intercourse to ensure its effectiveness in preventing pregnancy. The diaphragm acts as a barrier that blocks sperm from entering the cervix, and it must remain in place long enough for the spermicide (if used) to be effective in killing sperm. If removed too soon, the barrier may not provide adequate protection. After 6 hours, it is safe to remove the diaphragm, but it should not be left in place for longer than 24 hours to avoid the risk of infection or irritation. Explanation for the incorrect options: A. Immediately after intercourse Removing the diaphragm immediately after intercourse is not recommended. The diaphragm needs time to prevent sperm from reaching the cervix, and removing it too soon can compromise its contraceptive effectiveness. The spermicide may not have had enough time to act on the sperm, and the diaphragm may not provide adequate protection if removed prematurely. B. 1 hour after intercourse While 1 hour after intercourse is better than immediate removal, it is still not long enough for the diaphragm to provide maximum effectiveness. As mentioned, the diaphragm should ideally remain in place for at least 6 hours to ensure that sperm are neutralized and to reduce the risk of pregnancy. D. 12 hours after intercourse Although keeping the diaphragm in for longer than the minimum required time (6 hours) may not cause harm, 12 hours is unnecessary. Keeping it in for this long could increase the risk of vaginal irritation, dryness, or infection. It is recommended to remove the diaphragm within 6-8 hours after intercourse, and 12 hours is beyond what is necessary for contraceptive efficacy.",
      "correct_choice_id": 238695,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53394,
      "choices": [
        {
          "id": 238697,
          "text": "Inhibition of implantation"
        },
        {
          "id": 238698,
          "text": "Inhibition of fertilisation"
        },
        {
          "id": 238699,
          "text": "Inhibition of ovulation"
        },
        {
          "id": 238700,
          "text": "Inhibition of sperm motility"
        }
      ],
      "text": "All are mechanism of action of the contraceptive device shown except?<p><img src=\"https://d2enu63wt1sf3u.cloudfront.net/ckfinder/files/Q24(5).jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q1546579",
      "question_audio": null,
      "question_video": null,
      "map_id": 34704341,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Inhibition of ovulation. Contraceptive devices, including intrauterine devices (IUDs), work primarily by mechanisms that do not involve inhibiting ovulation. The IUD mainly functions through local effects on the uterus and cervical mucus, creating an environment that is hostile to sperm and preventing implantation, rather than directly interfering with the ovulation process. In some cases, hormonal IUDs (such as Mirena) can have secondary effects on ovulation, but this is not the primary mechanism of action for the device itself. Explanation for the incorrect options: A. Inhibition of implantation This is one of the primary mechanisms of action of most intrauterine contraceptive devices, especially non-hormonal copper IUDs. The presence of the IUD in the uterine cavity triggers a local inflammatory response that makes the uterine lining unsuitable for implantation of a fertilized egg. This is a key way that IUDs prevent pregnancy. B. Inhibition of fertilisation IUDs, particularly those with copper, also affect sperm motility and may prevent sperm from reaching and fertilizing an egg. Copper ions released by the IUD create a toxic environment for sperm, reducing the likelihood of fertilization. This is another important mechanism through which the IUD prevents pregnancy. D. Inhibition of sperm motility Copper IUDs specifically create an environment in the uterus that impairs sperm motility, reducing the sperm's ability to reach and fertilize the egg. This is a significant mechanism in the action of copper IUDs, contributing to their contraceptive effectiveness.",
      "correct_choice_id": 238699,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53395,
      "choices": [
        {
          "id": 238701,
          "text": "History of or current thromboembolism"
        },
        {
          "id": 238702,
          "text": "Coronary artery disease"
        },
        {
          "id": 238703,
          "text": "Tobacco use of greater than or equal to 15 cigarettes/day over the age of 35 years"
        },
        {
          "id": 238704,
          "text": "Diabetes Mellitus"
        }
      ],
      "text": "All of the following are absolute contraindications to COC pill use, except:",
      "unique_key": "Q2177615",
      "question_audio": null,
      "question_video": null,
      "map_id": 34534924,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Diabetes Mellitus. Diabetes mellitus, by itself, is not considered an absolute contraindication for the use of combined oral contraceptive (COC) pills. While diabetes can increase the risk of cardiovascular diseases, which may necessitate caution when prescribing COCs, it does not outright contraindicate their use in the absence of complications like retinopathy, nephropathy, or other vascular conditions. Women with well-controlled diabetes and no complications can typically use COCs safely, though individual risk factors should always be considered. Explanation for the incorrect options: A. History of or current thromboembolism A history of thromboembolism (such as deep vein thrombosis or pulmonary embolism) is a well-established absolute contraindication to the use of COCs. Estrogen-containing contraceptives can increase the risk of blood clot formation, making them unsafe for individuals with a history of thromboembolic events. B. Coronary artery disease Women with coronary artery disease (CAD) should not use combined oral contraceptives because of the increased risk of heart attack, stroke, and other cardiovascular events due to the prothrombotic effects of estrogen. CAD is an absolute contraindication to COCs. C. Tobacco use of greater than or equal to 15 cigarettes/day over the age of 35 years Smoking is a significant risk factor for cardiovascular disease, and in women over 35 years old, it increases the risk of adverse cardiovascular events, such as heart attacks and strokes, when combined with estrogen-containing contraceptives. This makes tobacco use of greater than or equal to 15 cigarettes per day a contraindication for the use of COCs in women over 35.",
      "correct_choice_id": 238704,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53396,
      "choices": [
        {
          "id": 238705,
          "text": "Leave the IUD in place without any other treatment."
        },
        {
          "id": 238706,
          "text": "Leave the IUD in place and continue prophylactic antibiotics throughout pregnancy."
        },
        {
          "id": 238707,
          "text": "Remove the IUD immediately."
        },
        {
          "id": 238708,
          "text": "Terminate the pregnancy because of the high risk of infection."
        },
        {
          "id": 238709,
          "text": "Perform a laparoscopy to rule out a heterotopic ectopic pregnancy"
        }
      ],
      "text": "An intrauterine pregnancy of approximately 10 weeks gestation is con?rmed in a 30-year-old G5P4 woman with an IUD in place. The patient expresses a strong desire for the pregnancy to be continued. On examination, the string of the IUD is noted to be protruding from the cervical os. Which of the following is the most appropriate course of action?",
      "unique_key": "Q6826792",
      "question_audio": null,
      "question_video": null,
      "map_id": 34192771,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Remove the IUD immediately. In a pregnant woman with an intrauterine device (IUD) in place, especially when the string is visible and protruding from the cervical os, the most appropriate course of action is to remove the IUD as soon as possible. Retaining the IUD during pregnancy, even in the early stages, increases the risk of complications such as miscarriage, preterm labor, and infection. The IUD itself does not provide contraception once the woman is pregnant, and removing it is critical to reduce the risk of infection and pregnancy loss. If the device is left in place, it may also cause harm to the developing pregnancy, and removing it reduces the likelihood of adverse outcomes. Explanation for the incorrect responses: A. Leave the IUD in place without any other treatment. Leaving the IUD in place during pregnancy is not recommended because it increases the risk of infection, spontaneous abortion, and preterm labor. Even if the woman desires to continue the pregnancy, the IUD should be removed promptly to ensure the best chance for a healthy pregnancy. B. Leave the IUD in place and continue prophylactic antibiotics throughout pregnancy. While antibiotics may be prescribed for certain infections, this approach does not address the risks of retaining an IUD during pregnancy. The main concern is the risk of miscarriage, infection, and uterine irritation caused by the IUD, which antibiotics cannot entirely prevent. The IUD should be removed, not just treated with antibiotics. D. Terminate the pregnancy because of the high risk of infection. While the presence of an IUD in pregnancy can increase the risk of infection and other complications, termination is not the immediate solution unless there are specific indications, such as an ectopic pregnancy or significant fetal or maternal compromise. If the pregnancy is intrauterine and the woman wishes to continue, removal of the IUD is the most appropriate action. E. Perform a laparoscopy to rule out a heterotopic ectopic pregnancy. Heterotopic pregnancies (a coexisting intrauterine and ectopic pregnancy) are rare, and there is no indication from the scenario that this is a concern. The first step in this case should be the removal of the IUD, as it is the primary intervention needed for the woman's pregnancy management. If there were signs of an ectopic pregnancy, further imaging or investigation might be necessary, but laparoscopy would not be the first step in this scenario.",
      "correct_choice_id": 238707,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53397,
      "choices": [
        {
          "id": 238710,
          "text": "Contraindicated in women with migraine headaches"
        },
        {
          "id": 238711,
          "text": "May worsen acne"
        },
        {
          "id": 238712,
          "text": "Inhibition of ovulation is the main mechanism of action"
        },
        {
          "id": 238713,
          "text": "Decrease risk of ovarian cyst"
        }
      ],
      "text": "Which of the following is true regarding the use of progestin-only pills?",
      "unique_key": "Q9772773",
      "question_audio": null,
      "question_video": null,
      "map_id": 34391099,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) May worsen acne. Progestin-only pills (POPs) can sometimes worsen acne. This is because the progestins in POPs, which are synthetic forms of the hormone progesterone, may increase the production of sebum (skin oil), which can lead to acne in some women. While this effect is not universal, it is a known side effect of progestin-based contraceptives. Explanation for the incorrect responses: A. Contraindicated in women with migraine headaches This statement is not true. Progestin-only pills are often considered a safer option for women who suffer from migraines, particularly those with aura, who are contraindicated for combined oral contraceptives (COCs) due to the risk of stroke. Progestin-only pills do not carry the same stroke risk, so they may actually be preferred for migraine sufferers. C. Inhibition of ovulation is the main mechanism of action This is incorrect because while POPs can suppress ovulation, it is not their primary mechanism of action. The primary way POPs prevent pregnancy is by thickening the cervical mucus, which makes it difficult for sperm to reach the egg. In some women, ovulation may be suppressed, but this is not the most consistent mechanism for all users. D. Decrease risk of ovarian cyst This is incorrect. While combined oral contraceptives (COCs) can reduce the risk of ovarian cysts, progestin-only pills do not have the same effect. In fact, some women using POPs may still experience ovarian cysts, although they are generally less frequent compared to women not using hormonal contraception. Therefore, POPs do not specifically decrease the risk of ovarian cysts.",
      "correct_choice_id": 238711,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53398,
      "choices": [
        {
          "id": 238714,
          "text": "If an established pregnancy is present use of Plan B will cause an abortion."
        },
        {
          "id": 238715,
          "text": "Mifepristone is less effective than the Yuptze method."
        },
        {
          "id": 238716,
          "text": "The major mechanism of action of emergency hormone contraceptives is inhibition or delay of ovulation"
        },
        {
          "id": 238717,
          "text": "The emergency contraceptive, Plan B, requires a prescription."
        }
      ],
      "text": "Which of the following statements is true regarding emergency contraception?",
      "unique_key": "Q1691814",
      "question_audio": null,
      "question_video": null,
      "map_id": 34665675,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) The major mechanism of action of emergency hormone contraceptives is inhibition or delay of ovulation. Emergency contraception, including methods like Plan B (levonorgestrel), primarily works by delaying or inhibiting ovulation. By preventing or delaying the release of an egg from the ovary, emergency contraceptives reduce the likelihood of sperm fertilizing the egg. This mechanism is crucial because if fertilization does not occur, pregnancy cannot happen. Emergency contraception does not cause abortion once pregnancy is established, and it is not effective if taken after implantation has occurred. Explanation for the incorrect responses: A. If an established pregnancy is present, use of Plan B will cause an abortion. This statement is false. Plan B or emergency contraception does not induce abortion. If a pregnancy is already established, taking Plan B will not have any effect. Emergency contraception only works before fertilization or implantation occurs. It is not effective after implantation, and it cannot terminate an existing pregnancy. B. Mifepristone is less effective than the Yuptze method. This is incorrect. Mifepristone (often used in medical abortions) is more effective than emergency contraceptive methods like the Yuzpe regimen (which combines high-dose estrogen and progestin). Mifepristone is primarily used for terminating an existing pregnancy and is not considered a form of emergency contraception. The Yuzpe method is less effective and has more side effects compared to other forms of emergency contraception. D. The emergency contraceptive, Plan B, requires a prescription. This statement is incorrect in many places. In most countries, including the United States, Plan B (levonorgestrel) can be obtained without a prescription over-the-counter for individuals of any age. However, the regulations might vary by country, and in some places, a prescription may be required.",
      "correct_choice_id": 238716,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53399,
      "choices": [
        {
          "id": 238718,
          "text": "Copper intrauterine device (IUD)"
        },
        {
          "id": 238719,
          "text": "Levonorgestrel IUD"
        },
        {
          "id": 238720,
          "text": "Combination oral contraceptive agent"
        },
        {
          "id": 238721,
          "text": "Condom (barrier method)"
        }
      ],
      "text": "A 38-year-old woman is seen in the office desiring contraception. She has a 7-year history of chronic hypertension, which is controlled with sustained release nifedipine . She smokes about a pack of cigarettes each day. She complains of dysmenorrhea and heavy menses with clots. Which of the following is the best contraceptive agent for this patient?",
      "unique_key": "Q3683452",
      "question_audio": null,
      "question_video": null,
      "map_id": 34676903,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Levonorgestrel IUD. In this case, the best contraceptive method for a 38-year-old woman with chronic hypertension controlled by nifedipine and a history of heavy, painful menses (dysmenorrhea) is the levonorgestrel IUD. The levonorgestrel intrauterine device (IUD) not only provides highly effective contraception but also has the added benefit of reducing menstrual bleeding and alleviating dysmenorrhea. The progestin released by the IUD thins the endometrial lining, which can significantly reduce heavy menstrual bleeding, making it a suitable option for this patient who is experiencing heavy menses with clots. Additionally, the IUD does not carry the same cardiovascular risks as combined hormonal contraception, making it safer for a patient with chronic hypertension. Explanation for the incorrect responses: A. Copper intrauterine device (IUD): While the copper IUD is also an effective contraceptive, it may not be the best choice for this patient due to her heavy menstrual bleeding. The copper IUD can actually increase menstrual bleeding and cramping, which would likely worsen her symptoms of dysmenorrhea and heavy menses with clots. Therefore, it is less appropriate for this particular case. C. Combination oral contraceptive agent: Combination oral contraceptives (COCs) are not ideal for women with chronic hypertension, especially those who smoke. The combination of smoking and COCs increases the risk of thromboembolic events, including stroke and deep vein thrombosis (DVT), particularly in women over 35. This patient’s smoking habit and history of hypertension make COCs less appropriate due to the increased cardiovascular risks. D. Condom (barrier method): While condoms provide effective contraception and protection against sexually transmitted infections (STIs), they are less reliable for contraception compared to other methods, such as IUDs. In this case, the patient is seeking a more reliable and long-term contraceptive method. Condoms also do not address the patient’s complaint of dysmenorrhea and heavy menstrual bleeding.",
      "correct_choice_id": 238719,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53400,
      "choices": [
        {
          "id": 238722,
          "text": "CuT"
        },
        {
          "id": 238723,
          "text": "LNG tablet"
        },
        {
          "id": 238724,
          "text": "Yuzpe"
        },
        {
          "id": 238725,
          "text": "RU 486"
        }
      ],
      "text": "Which of the following is the least effective method of emergency contraceptive",
      "unique_key": "Q4327234",
      "question_audio": null,
      "question_video": null,
      "map_id": 34147898,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Yuzpe. The Yuzpe method is the least effective form of emergency contraception. This method involves taking a combination of regular oral contraceptive pills (containing both estrogen and progestin) within a specific time frame after unprotected intercourse. While it is an option for emergency contraception, its effectiveness is lower compared to other methods, especially when compared to methods like CuT (Copper IUD) or LNG (Levonorgestrel) tablets. The Yuzpe method typically has a higher failure rate, mainly due to the complexity of dosing and the need for higher hormone doses that can cause significant side effects such as nausea and vomiting. Explanation for the incorrect responses: A. CuT (Copper IUD): The Copper IUD is one of the most effective forms of emergency contraception. When inserted within 5 days after unprotected intercourse, it not only prevents implantation but also has a failure rate of less than 1%. It is highly effective and acts as a long-term contraceptive method once in place, making it far more effective than the Yuzpe method for emergency contraception. B. LNG (Levonorgestrel) tablet: Levonorgestrel (LNG) tablets, commonly sold as Plan B or Next Choice, are highly effective when taken within 72 hours of unprotected intercourse. They work by inhibiting or delaying ovulation and are easier to use with fewer side effects than the Yuzpe method. Their failure rate is lower compared to Yuzpe, making them one of the preferred options for emergency contraception. D. RU 486 (Mifepristone): RU 486, or Mifepristone, is an effective emergency contraceptive that can be used up to 5 days after unprotected sex. It is typically used in combination with misoprostol for medical abortion but is also effective as emergency contraception when used alone. The effectiveness of mifepristone in preventing pregnancy is high, and its use in emergency contraception is well-supported by clinical evidence.",
      "correct_choice_id": 238724,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    }
  ]
}